Untitled

Free English translation for information purposes only

Limited Liability Company (Naamloze Vennootschap)

Zinkstraat 1, 2490 Balen (Belgium)

Company number VAT BE 0888.728.945 RPR/RPM Turnhout

_________________________________________________

Report of the board of directors ex article 3:6 Belgian Code of Companies and Associations

_________________________________________________

Pursuant to articles 3:5 and 3:6 of the Belgian Code of Companies and Associations, we are hereby reporting to you on the

operations of Nyrstar NV (the “Company”) with respect to the financial year as from 1 January 2024 until 31 December 2024.

This report comprises also the corporate governance statement and remuneration report in accordance with article 3:6 §2 and

§3 of the Belgian Code of Companies and Associations as attached to this report in annex C and D respectively.

1. Company facts and activities

The Company has its registered office at Zinkstraat 1, Balen, Belgium. The Company has been listed on Euronext Brussels

since 29 October 2007.

Until 31 July 2019, the Company was the holding company of the Nyrstar Group (consisting of Nyrstar NV and its subsidiaries).

In addition, until 31 July 2019, the Company delivered a number of support services to the Nyrstar Group, such as, but not

limited to, regional purchasing, IT, environment, innovation and development, continuous improvement and legal support

services. Following the completion of the restructuring of the Nyrstar group at 31 July 2019 (described in more detail in section

2 below), the Company intended to continue trading as an investment company, holding 2% of the equity in NN2 NewCo

Limited (“NN2”) for the benefit of the Company’s shareholders.

At 9 December 2019, the Extraordinary General Meeting (“EGM”) of the Company was held to deliberate on the continuation

of the Company's activities and a proposed capital decrease. The shareholders rejected the continuation of the Company's

activities. As such, the 31 December 2024 financial statements of the Company are prepared on a discontinuity basis. As the

result of an order of 26 June 2020 of the President of the Antwerp Enterprise Court (Antwerp division), at the request of a

group of shareholders, the Company was prohibited from holding a general meeting with the dissolution of the Company on

the agenda until three months after a final decision on the appointment of a college of experts (see below, under section 8.3)

would have obtained res judicata effect.

As announced on 14 February 2023, in light of the announcement in the press that certain shareholders of the Company would

file a Supreme Court appeal against the judgment of the Antwerp Court of Appeal dated 17 November 2022 with respect to

the claim for the appointment of a panel of experts (which appeal has meanwhile been dismissed by judgment dated 2 May

2024), the Company was of the opinion that it was not opportune to carry out its obligation to place the dissolution on the

agenda pending the Supreme Court appeal. The Company thus announced that it would not take steps to convene a general

meeting with dissolution as an agenda item (or take preparatory actions to that effect) until the Supreme Court’s judgment,

and that it would update the market by then. On 2 May 2024, the Supreme Court rejected the shareholders’ appeal. The

Company announced the same day that it would not submit the dissolution or the continuation of the Company to the general

meeting at that time and that it would revert to this matter no sooner than after a decision by the Antwerp Enterprise Court

(Turnhout division) on the petition for interim measures filed by a group of minority shareholders on 11 March 2024. Following

the decision of 9 January 2025 by the Antwerp Commercial Court (Turnhout division) to postpone the assessment on the

merits of the petition for interim measures, the Company announced on 6 February 2025 that it did not deem it in the best

interest of the Company at this stage to submit the dissolution or the continuation of the Company to the general meeting of

shareholders and that it would assess whether this position is to be reconsidered in the corporate interest of the Company,

including if and when there are any further developments.

Free English translation for information purposes only

Under article 3:23 of the Belgian Code of Companies and Associations, a parent company that controls one or more

subsidiaries is required to prepare consolidated financial statements, unless such subsidiaries are, in view of the consolidated

assets, financial position or the consolidated results, individually and together, only of a negligible significance. Given that, as

at 31 December 2024, Nyrstar NV did not control any significant subsidiary, the Company was not required to prepare

consolidated financial statements for the year ended 31 December 2024. In accordance with article 12, §3, final paragraph, of

the Royal Decree of 14 November 2007, the Company has prepared the 31 December 2024 standalone statutory financial

statements in accordance with Belgian GAAP.

2. Restructuring of the Nyrstar group

In October 2018, the former Nyrstar group initiated a review of its capital structure (the "Capital Structure Review") in response

to the challenging financial and operating conditions being faced by the Nyrstar group. The Capital Structure Review identified

a very substantial additional funding requirement that the Nyrstar group was unable to meet without a material reduction of

the Nyrstar group's indebtedness. As a consequence, the Capital Structure Review necessitated negotiations between the

Nyrstar group's financial creditors that ultimately resulted in the restructuring of the Nyrstar group, which became effective on

31 July 2019 (the “Restructuring”). As a result of the Restructuring, Trafigura Group Pte. Ltd., via its indirect 98% ownership

of the new holding company NN2 Newco Limited (“NN2”), became the ultimate parent company of the former (direct and

indirect) subsidiaries of the Company (the "Operating Group”), with the remaining 2% stake in NN2 (and thereby the Operating

Group) being owned by the Company.

The agreements to which the Company is or was a party are discussed in further detail below.

2.1. The NNV-Trafigura Deed

The lock-up agreement (“Lock-Up Agreement”) entered into on 14 April 2019 between, among others, the Company and

representatives of its key financial creditor groups, envisaged that the Company, Trafigura Pte Ltd (“Trafigura”) and Nyrstar

Holdings Limited ("Nyrstar Holdings", a Trafigura special-purpose vehicle incorporated, amongst other things, for the purpose

of implementing the Restructuring, now known as Nyrstar Holdings Plc) would enter into a deed confirming their agreement in

respect of (i) certain steps necessary for the implementation of the restructuring as envisaged in the Lock-Up Agreement and

(ii) the terms of the ongoing relationship between the Company and the Trafigura group (the "NNV-Trafigura Deed"). The NNV-

Trafigura Deed was duly executed on 19 June 2019.

Certain key terms of the NNV-Trafigura Deed namely those governing the distributions policy, drag / tag rights and change of

control in respect of NN2, have previously been described in the Company’s related party disclosures. However, following the

exercise of the Put Option (as defined below and on which, see 2.2 below for more details) and the Company ceasing to be a

shareholder of NN2, these provisions of the NNV-Trafigura Deed are no longer relevant / no longer apply.

Under the provisions of the NNV-Trafigura Deed that continue notwithstanding the exercise of the Put Option and the Company

ceasing to be a shareholder of NN2, the Company continues to benefit from a right (subject to compliance with applicable law

and any relevant confidentiality obligations) to make reasonable requests of Trafigura to procure that the Company is provided

with financial or other information in relation to the Operating Group (or any member of it).

2.2. The Put Option Deed

Pursuant to the NNV-Trafigura Deed, the Company and Trafigura also agreed that Trafigura shall grant to the Company an

option to require a Trafigura entity to purchase the Company's entire interest in NN2. The terms of this option are set out in a

separate deed, dated 25 June 2019, between the Company, Trafigura and Nyrstar Holdings (the "Put Option Deed"). Under

the terms of the Put Option Deed, the Company could put all (but not only a part) of its 2% holding in NN2 to Trafigura at a

price equal to EUR 20 million (the "Put Option").

On 18 November 2021, the Company announced that it had appointed Moore Corporate Finance to prepare an independent

expert’s opinion for the independent directors of the Company (“Committee of Independent Directors”), in the framework of

Free English translation for information purposes only

Article 7:97 of the Belgian Code of Companies and Associations. The independent expert’s opinion was to advise

the Committee of Independent Directors in examining the benefit to the Company, taking all relevant circumstances into

account, of the exercise or non-exercise of the Put Option that the Company had in relation to its entire 2% investment in

NN2.

On 28 July 2022, the Company publicly announced that the Board had completed its detailed review process in respect of the

decision whether or not to exercise the Put Option related to its entire 2% shareholding in NN2. Considering the independent

expert report prepared by Moore Corporate Finance, which valued the 2% shareholding in NN2 in a range of EUR 0

million to EUR 3.4 million, the opinion of the independent directors of the Company, questions and comments raised by certain

minority shareholders and other information made available to it, the Board decided that it was in the corporate benefit of the

Company to exercise the Put Option. On 28 July 2022, the Company duly gave notice to Nyrstar Holdings Plc and to Trafigura

Pte Ltd. that it exercised the Put Option in accordance with the terms of the Put Option Deed. The Company received the

proceeds from the exercise of the Put Option on 29 July 2022.

Documentation in respect of the Company’s decision to exercise the Put Option was published on the Company’s website

nyrstarnv.be on 28 July 2022. In addition, a memo of Moore Law was published on 17 November 2022 on the Company’s

website, at the request of several shareholders. These documents remain available there as at the date of this report.

We refer in this respect to the related party disclosures included in the annual accounts for the financial year ended 31

December 2024 in respect of the mandatory prepayment obligations and limited recourse provisions under the Limited

Recourse Loan Facility (as defined below) that apply to the proceeds of the Put Option.

2.3. Release from parent company guarantees in favour of Trafigura

As stated above, prior to the effective date of the Restructuring which was 31 July 2019 (the “Restructuring Effective Date”),

the Company was the ultimate parent company of the Nyrstar group, and had previously issued various parent company

guarantees (the “PCGs”) in respect of the obligations of its subsidiaries, including, but not limited to, two parent company

guarantees (the "Trafigura PCGs") granted in respect of the primary financial obligations of the Company's indirect subsidiary

at that time, Nyrstar Sales & Marketing AG ("NSM"), to Trafigura, namely under the USD 650 million Trade Finance Framework

Agreement ("TFFA") and the USD 250 million Bridge Finance Facility Agreement ("BFFA"). The Trafigura PCGs as well as all

other security and / or guarantees provided to Trafigura by the Operating Group in respect of the TFFA and BFFA, were

released in full on the Restructuring Effective Date.

2.4. Release from parent company guarantees in favour of third parties and the Company's rights to indemnification by NN2

under the NNV-NN2 SPA

Prior to, and as part of the implementation of, the Restructuring, the Company entered into an agreement for the sale and

transfer by the Company of substantially all of its assets including 100% of its shareholding in Nyrstar Netherlands (Holdings)

BV and also its holdings (direct and indirect) in its subsidiaries, but excluding its shares in NN1 NewCo Limited ("NN1"), to

NN2 (the “NNV-NN2 SPA”). Under the NNV-NN2 SPA, the Company benefits from contractual agreements with NN2 and

Trafigura in respect of its release from, or indemnification for, liabilities for existing financial indebtedness and obligations owed

to third parties in respect of financial, commercial or other obligations of the then current members of the Operating Group (the

"PCGs"), such that those third parties should no longer have recourse to the Company. The release and / or indemnification

obligations of NN2 from which the Company benefits can be summarised as follows.

- Release of PCGs and general indemnity: The NNV-NN2 SPA includes a commitment by NN2 to use reasonable

endeavors to procure the release of obligations owed by the Company under third-party PCGs. This obligation is

combined with an obligation on NN2 to indemnify the Company, to the extent such PCGs are not released, for any

and all liabilities in relation to such PCGs in respect of the failure by the applicable member of the Operating Group

to comply fully with its principal obligations.

Free English translation for information purposes only

- Indemnity for specified historic liabilities: Further, the NNV-NN2 SPA also contains an obligation on NN2 to indemnify

the Company, to the extent not covered by the release and/or indemnification of PCGs mentioned above, in respect

of certain specified liabilities, including certain liabilities arising in relation to certain historic disposals by the former

Nyrstar group and/or from certain historic mine closures, which are specified in a schedule to the NNV-NN2 SPA.

- Limitation on recourse to the Company of former subsidiaries: To limit and release further any financial obligations

on the Company, the NNV-NN2 SPA obliges NN2 to procure that, and the NNV-Trafigura Deed obliges Trafigura to

procure that, no former subsidiaries of the Company will make any demands for payment from the Company except

(i) under the Limited Recourse Loan Facility, (ii) as otherwise agreed following the completion of the Restructuring;

or (iii) to the extent that the Company has sufficient funds available (excluding any dividends or sale proceeds in

respect of the Company's (now sold) direct 2% shareholding in NN2).

2.5. Financial transactions with Trafigura entities - the Limited Recourse Loan Facility

2.5.1. Introduction

On 23 July 2019, the Company entered into a EUR 13.5 million committed, limited recourse, loan facility (the "Limited Recourse

Loan Facility") provided to it by NN2 (as "Lender"). The key terms of the Limited Recourse Loan Facility are described below.

The Limited Recourse Loan Facility is made available in two separate tranches: (i) up to EUR 8.5 million to be applied towards

the Company's ongoing ordinary course operating activities ("Facility A"); and (ii) up to EUR 5 million intended for the payment

of certain costs related to litigation defense ("Facility B"). No security, collateral or guarantees have been granted in respect

of the Company's obligations under the Limited Recourse Loan Facility.

2.5.2. Available commitments, amounts outstanding and interest

As at 31 December 2024, the Company owed EUR 6.6 million (2023: EUR 6.3 million) under Facility A. Facility A can be used

by the Company to cover day-to-day operating costs, including, without limitation, reasonable director and employee costs,

D&O insurance premium (to the extent not paid prior to the Restructuring Effective Date), audit fees, legal costs (except those

relating to litigation or other actual or threatened proceedings against the Company, which should be funded from Facility B

(defined below)), listing fees and investor relations costs. The funding under Facility A is provided to the Company based on

the quarterly cash flow forecast prepared by the Company and provided to Trafigura as a condition of the funding. The total

quantum of funds to be made available under Facility A was agreed based on the Company's forecast operating costs for a

five year period following the completion of the Restructuring, taking into account the ongoing operational services provided

to the Company by NN2, as agreed in the NNV-NN2 SPA, for a period of approximately three years from the Restructuring

Effective Date (the "Ongoing Services"). The Ongoing Services provided by NN2 to the Company included finance, tax,

corporate counsel, IT and administration services. The provision of the Ongoing Services to the Company was intended to

reduce the Company's operating costs in the period following the Restructuring Effective Date.

As at 31 December 2024, the Company had drawn EUR 3.9 million (2023: EUR 3.7 million) under Facility B. Subject to the

restrictions detailed below, Facility B can be applied by the Company towards payment or reimbursement of costs in respect

of any litigation, proceeding, action or claims (including tax claims) made, asserted or threatened against the Company, NN1

Newco Limited ("NN1") or any of their current or former directors or officers (each being a "Claim").

Under Facility A, the Company could borrow up to EUR 8.5 million before 31 July 2024. Funding under Facility B can be drawn

based on costs incurred in respect of any Claim (subject to the restrictions detailed below, and on the delivery of an invoice

for such costs). Utilisation of each Facility is limited to a maximum of three drawings per financial quarter per Facility (excluding

any PIK Loans (defined below)). As at the date of this report, the Company has drawn EUR 6.6 million under Facility A and

EUR 3.9 million under Facility B.

As a result of the exercise of the Put Option and the Company ceasing to be a shareholder of NN2, the "NNV Exit Date" (as

defined in the Limited Recourse Loan Facility) has occurred. The NNV Exit Date is specified as an Event of Default (as defined)

under the Limited Recourse Loan Facility, which gives NN2 (as Lender) the right to cancel (by notice to the Company) the

Free English translation for information purposes only

whole or any part of the Lenders' remaining commitments under the Limited Recourse Loan Facility. As at the date of this

report, NN2 has not exercised such right.

However, each utilisation request under the Limited Recourse Loan Facility must (unless otherwise agreed by the Lender) be

accompanied by a certificate signed by a director stating, among other things, that (in short) the Company's "Available Cash"

(as defined therein) is not sufficient to meet the anticipated costs and liabilities for which the relevant utilisation is intended.

Given the Company's receipt of EUR 20 million from the exercise of the Put Option in July 2022, it is not currently envisaged

that the Company would be able to make any further valid utilisation requests under the Limited Recourse Loan Facility.

The rate of interest on amounts outstanding under the Limited Recourse Loan Facility is the aggregate of EURIBOR plus a

margin of 0.5% per annum. It shall be payable within 10 business days of the anniversary of the date on which such amount

was made available, provided that such interest will be capitalised if it has accrued for a period of one year or more and the

Company has given a notice in the form prescribed by the Limited Recourse Loan Facility. Any interest which is capitalised

shall be treated as a new loan (a "PIK Loan") under the relevant Facility. Any PIK Loan shall itself accrue interest, and that

interest may also be capitalised. No payments of interest have been made by the Company as all payable interest until 31

December 2024 of EUR 753k (2023: 327k) has been capitalised into a new PIK Loan. The interest charges on the Limited

Recourse Loan Facility expensed in the Profit and Loss Account in the year ended 31 December 2024 were EUR 428k (2023:

368k).

2.5.3. Restrictions on use of proceeds

The Company must not use any amount borrowed under either Facility A or Facility B for funding (directly or indirectly) any of

the costs related to asserting or bringing or assisting in the pursuit of claims (including any counterclaim or defense) against

Trafigura, other members of the Trafigura group, NN2 and / or any Replacement Holdco, and / or any other member of the

Operating Group), against any of such entities' current or former directors, officers, or advisers, against any creditor in respect

of such entities (other than with the consent of NN2, such consent not to be unreasonably withheld or delayed) or in connection

with any challenge to the Restructuring, including in relation to the TFFA and the BFFA or any other document contemplated

by the Restructuring implementation deed.

2.5.4. Mandatory prepayment obligations

The provisions of the Limited Recourse Loan Facility that relate to mandatory prepayment out of "Excess Cash”, and which

were described in previous versions of this reports by the Company, have ceased to apply as a result of the Company ceasing

to be a shareholder of NN2 and having received the proceeds of the exercise of the Put Option (such proceeds constituting

"Disposal Proceeds” for the purposes of the Limited Recourse Loan Facility).

Immediately upon receipt of any Disposal Proceeds, and subject to the limited recourse provisions described below (see in

particular at 2.5.5, the Company shall procure that these shall be applied first to prepay any amount outstanding under Facility

B (being the litigation tranche), and secondly, if (i) any Disposal Proceeds remain after any required prepayment of Facility B,

and (ii) the aggregate amount of all amounts outstanding under Facility A (being the operational costs tranche) exceeds EUR

5 million, to prepay such Facility Amounts to or towards an aggregate amount of EUR 5 million.

The Company shall ensure that, if any distribution is paid to the Company's shareholders on or after the Company Exit Date,

an amount equal to that distribution is applied to repay or prepay amount outstanding under Facility A before or simultaneously

with such distribution.

The Company has also agreed that, if it receives any amounts from costs awards, damages awards and / or any other recovery

from any counterparty to a Claim (such amounts constituting "Claim Proceeds"), then such Claim Proceeds must be used

immediately to repay or prepay any amounts outstanding under Facility B.

Additionally, there are customary provisions that require mandatory prepayment of amounts outstanding under either or both

Facility A and B in the case of certain events of default that allow for acceleration by the Lender.

Free English translation for information purposes only

However, in accordance with the limited recourse provisions of the Limited Recourse Loan Facility (as detailed further at 2.5.5.

below), NN2’s recourse to the Company in respect of repayment of funds drawn or any other obligation thereunder is limited

to the Company's net assets, if any.

2.5.5. Limited recourse

As mentioned above, the recourse of NN2 as Lender under the Limited Recourse Loan Facility in respect of repayment thereof

or any other obligation of the Company thereunder is limited to the “Company Net Assets”, being the assets (including all

present and future properties, revenues and rights of every description) of the Company (other than assets held or received

on trust for a person which is not a member of Nyrstar or its subsidiaries) having satisfied or provided for its “Liabilities”

(meaning all present or future liabilities and obligations, both actual and contingent and whether incurred solely or jointly or as

principal or surety or in any other capacity), except for Liabilities of the Company under the Limited Recourse Loan Facility

and related finance documents which shall be disregarded for this purpose.

Further, to the extent that the Company Net Assets are insufficient to discharge the Company’s obligations under the Limited

Recourse Loan Facility, such obligations shall be deemed to be limited to the amount of the Company Net Assets, and the

Lender shall not be entitled to make a claim and shall have no further recourse against the Company and the Company shall

have no liability to pay or otherwise.

All actual, contingent and prospective liabilities would need to be factored in when calculating the Company Net Asset position.

The Company determined at the time of the exercise of the Put Option on 28 July 2022 and as at 31 December 2024, that it

is in the corporate benefit of the Company that, for the purposes of the mandatory prepayment, these liabilities are calculated

on a worst-case scenario basis, and not (i) in accordance with IFRS or Belgian GAAP, nor (ii) based upon the Company's

assessment of the likelihood of such contingent or prospective liabilities eventually materialising. Based on the Company's

estimates, the Company has determined that the Company Net Assets (as defined under the Limited Recourse Loan Facility)

are negative even taking into account the receipt of the proceeds of the Put Option, and that currently no repayments of the

Limited Recourse Loan Facility are necessary. The Company will, however, continue to monitor the development of its

Company Net Asset position until the completion of the liquidation process, to consider whether any repayment of the Limited

Recourse Loan Facility needs to be made.

However, this limitation on NN2’s recourse against the Company shall not apply to the extent that the value of the Company

Net Assets is impaired, or NN2 suffers loss as a result of any breach by the Company of any provision of the Limited Recourse

Loan Facility (or any related finance document) other than the repeating representations / warranties thereunder or the

provisions requiring payment of interest / fees or repayment / prepayment of principal thereunder.

2.5.6. Information, consultation and litigation strategy undertakings

So long as any amount is outstanding under the Limited Recourse Loan Facility or the Lender's commitment thereunder is still

in force, if any Claim arises as a result of which the Company reasonably anticipates that it may make a utilisation under

Facility B, the Company must must give notice to the Lender and Trafigura of the Claim. The Company shall:

- promptly notify NN2 and Trafigura of the Claim;

- subject to compliance with applicable law or confidentiality obligations to third parties, make available to NN2 and

Trafigura all information in its possession and control as reasonably requested by NN2 or Trafigura in connection

with assessing, contesting, disputing, defending, appealing or compromising the Claim, provided that NN2 and

Trafigura shall maintain confidentiality and/or privilege with regard to such information;

- keep NN2 and Trafigura informed of the progress / developments in respect of the Claim, and promptly provide any

correspondence or other information received in connection with the Claim;

Free English translation for information purposes only

- consult and take into account the views of NN2 and Trafigura as to the applicable legal advisors that will represent

the Company, NN1, or the applicable directors or officers. The Company shall also procure that such legal advisors

provide fee estimates as requested by NN2 or Trafigura;

- consult with and take into account the views of NN2 and Trafigura in relation to the conduct of the defense /

negotiations / settlements in respect of the Claim; and

- whilst any amount is outstanding under Facility B in relation to a civil Claim, not make any admission of liability,

agreement, settlement or compromise in relation to that Claim without the prior written approval of Trafigura.

The Company must also consult with Trafigura prior to taking any action relating to insolvency or bankruptcy proceedings,

including under Book XX of the Belgian Code of Economic Law.

The Company is also obliged to provide NN2 with certain financial information, including quarterly cashflow forecasts (and any

revisions thereto required under the terms of the Limited Recourse Loan Facility), half-yearly financial statements and audited

annual financial statements, drawn up on a consolidated basis (to the extent the Company has subsidiaries) and in accordance

with the accounting principles agreed under the terms of the Limited Recourse Loan Facility.

2.6. Relationship Agreement

At the completion of the Restructuring at 31 July 2019, the "Relationship Agreement" between Trafigura Group Pte Ltd and

the Company (dated 9 November 2015) was terminated. The Relationship Agreement governed the relationship between the

Company (and the broader Nyrstar Group) and Trafigura Group Pte. Ltd. and its affiliated persons between its execution on 9

November 2015 and the completion of the Restructuring on 31 July 2019.

Impact of the Restructuring on the 31 December 2024 financial statements

As at 31 December 2024, based on the information available to the Company, the Company has been fully released from all

contingent liabilities previously provided or irrevocably promised by the Company for debts and commitments of third parties

that were yet to be transferred to the Trafigura group for which the Company has been indemnified. The Company is fully

indemnified in relation to any liability that may arise in this respect (see "Related party disclosures"). For more details, refer to

the parent company guarantees disclosures in note C 6.14 and C 6.20.

Before 28 July 2022, the Company had, in its current investments, a 2% investment in NN2 at the cost of EUR 15,395,000.

The investment in NN2 of EUR 15,395,000 was carried at the lower of cost and fair value, taking into consideration that the

Company had a Put Option (as defined above) that enabled it to sell all (but not part only) of its 2% holding in NN2 to Trafigura

at a price equal to EUR 20 million in aggregate payable to the Company.

On 18 November 2021, the Company announced that it had appointed Moore Corporate Finance, to prepare an independent

expert’s opinion for the independent directors of the Company (“Committee of Independent Directors”), in the framework of

Article 7:97 of the Belgian Code of Companies and Associations. The independent expert’s opinion is to advise the Committee

of Independent Directors in examining the benefit to the Company, taking all relevant circumstances into account, of the

exercise or non-exercise of the Put Option that the Company has in relation to its (entire) 2% investment in NN2.

On 28 July 2022, the Company publicly announced that the Board had completed its detailed review process in respect of the

decision whether or not to exercise the Put Option related to its entire 2% shareholding in NN2. Considering the independent

expert report prepared by Moore Corporate Finance, which valued the 2% shareholding in NN2 in a range of EUR 0 million to

EUR 3.4 million, the opinion of the independent directors of the Company, questions and comments raised by certain minority

shareholders and other information made available to it, the Board decided that it was in the corporate benefit of the Company

to exercise the Put Option. On 28 July 2022, the Company duly gave notice to Nyrstar Holdings Plc and to Trafigura Pte Ltd.

that it exercised the Put Option in accordance with the terms of the Put Option Deed. The Company received the proceeds

from the exercise of the Put Option on 29 July 2022.

Free English translation for information purposes only

Documentation in respect of the Company's decision to exercise the Put Option was published on the Company's website

nyrstarnv.be on 28 July 2022. In addition, a memo of Moore Law was published on 17 November 2022 on the Company’s

website, at the request of several shareholders. These documents remain available there as at the date of this report.

Outcome of the Extraordinary General Meeting of the Company held at 9 December 2019

At 9 December 2019, an EGM was held to deliberate on the continuation of the Company's activities and a proposed capital

decrease. The shareholders rejected the continuation of the Company's activities. The shareholders also rejected the

proposed capital reduction, as a result of which it was not carried out.

As explained above, the Board of Directors of the Company convened a new EGM to formally decide on the dissolution of the

Company, and if approved, appoint a liquidator. However, as a result of an order of 26 June 2020 of the President of the

Antwerp Enterprise Court (Antwerp division), at the request of a group of shareholders, the Company was prohibited from

holding a general meeting with the dissolution of the Company on the agenda until three months after a final decision on the

appointment of a college of experts (see below, under section 8.3) would have obtained res judicata effect. As announced on

14 February 2023, in light of the announcement in the press that certain shareholders of the Company would file a Supreme

Court appeal against the judgment of the Antwerp Court of Appeal dated 17 November 2022 with respect to the claim for the

appointment of a panel of experts (which appeal has meanwhile been dismissed by judgment dated 2 May 2024), the Company

was of the opinion that it was not opportune to carry out its obligation to place the dissolution on the agenda pending the

Supreme Court appeal. The Company thus announced that it would not take steps to convene a general meeting with

dissolution as an agenda item (or take preparatory actions to that effect) until the Supreme Court’s judgment, and that it would

update the market by then. On 2 May 2024, the Supreme Court rejected the shareholders’ appeal. The Company announced

the same day that it would not submit the dissolution or the continuation of the Company to the general meeting at that time

and that it would revert to this matter no sooner than after a decision by the Antwerp Enterprise Court (Turnhout division) on

the petition for interim measures filed by a group of minority shareholders on 11 March 2024..

Following the decision of 9 January 2025 by the Antwerp Enterprise Court (Turnhout division) to postpone the assessment on

the merits of the petition for interim measures on 11 March 2024 filed by a group of shareholders, the Company announced

on 6 February 2025 that it will not at this stage submit the dissolution or continuation of the Company to the general meeting

at that time and that it would assess whether this position is to be reconsidered in the corporate interest of the Company,

including if and when there are any further developments.

3. Comments on the statutory financial statements

These comments are based on the balance sheet and the proposed allocation of results and are therefore subject to the

approval of the proposed allocation of results by the shareholders of the Company. The statutory financial statements were

prepared in accordance with Belgian accounting laws.

During the last financial year, the Company generated a net loss of EUR 4,471k and has a balance sheet total as at 31

December 2024 of EUR 13,343k.

Operating result

The operating result shows a loss of EUR 4,500k. This result derives from an operating income amounting to EUR 1,889k and

the operating charges of EUR 6,390k.

The operating income is primarily related to the refunds of the various legal costs by the Directors and Officers’s insurers of

the Company.

The operating costs mainly relate to services and other goods for EUR 5,040k, mainly related to audit fees, legal and

advisory fees, directors fees and other administrative services.

Free English translation for information purposes only

Financial result

The financial result mainly relates to:

- interest income of EUR 461k;

- interest charges of EUR 428k; and

- other financial charges of EUR 3k;

Income taxes

There has been no income tax expense incurred during 2024.

Balance sheet

The current assets at 31 December 2024 consist of:

- term deposits with a credit institution of EUR 11,000k.

- other receivables for EUR 551k include VAT, social security and other refunds outstanding at 31 December 2024;

- cash at bank for EUR 1,520k and

- deferred expenses of EUR 272k related mainly to insurance fees, audit fees, other advisory fees, refunds for the legal

and related expenses that are covered by the D&O insurance of the Company and the accrued interest income.

The equity as at 31 December 2024 amounted to negative EUR 8,432k.

The changes in equity for the financial year 2024 relate to the loss of EUR 4,471k.

The liabilities as at 31 December 2024 mainly relate to:

- The loan of EUR 10,486k drawn by the Company at 31 December 2024 on the Limited Recourse Loan Facility

provided to the Company by NN2.

- EUR 10,745k provision that includes the provision for discontinuation of EUR 10,733k (refer to section “Justification

of the application of the valuation rules under the assumption of discontinuity”)

- trade payables for EUR 343k that include outstanding operating liabilities and the legal invoices that are covered by

the D&O insurance of the Company;

- tax and payroll liabilities for EUR 22k; and

- accruals of EUR 180k representing the interest accrued on the Limited Recourse Loan Facility.

4. Result allocation (in EUR)

The Board of Directors proposes to allocate the current year loss of EUR 4,471k to the losses carried forward.

Free English translation for information purposes only

5. Risk management and management of uncertainties and information regarding the use by the Company of

financial instruments

The Company has invested the majority of the proceeds received from the exercise of the Put Option into the short-term

deposits while maintaining sufficient day-to-day liquidity.

For information on the Company’s risk management and management of uncertainties and information regarding the use by

the Company of financial instruments, please refer to the Corporate Governance Statement of the Company.

6. Justification of the application of the valuation rules under the assumption of discontinuity

As a consequence of the Restructuring and the outcomes of the 9 December 2019 EGM, where the shareholders rejected

the continuation of the Company's activities, the 31 December 2024 financial statements of the Company are prepared on a

discontinuity basis.

At the date of authorisation of the 31 December 2024 financial statements, the Company has assessed that, taking into account

its available cash, cash equivalents and its cash flow projections for the next 12 months from the authorisation by the Board

of Directors of the 31 December 2024 financial statements, it has sufficient liquidity to meet its present obligations and cover

working capital needs. The forecast available liquidity of the Company includes cash and cash term deposits of EUR 12.5

million as of 31 December 2024 and is dependent on various matters including the possible appointment of a liquidator and

his next steps, the existence and extent of the legal claims against the Company which could require funding of these legal

proceedings and other matters not currently foreseen as described in section d) of the valuation rules above. If the appointment

of the liquidator is further delayed or not approved by the shareholders or if the costs are higher than currently expected, the

Company may need to secure additional funding. There is a risk that such additional funding may not be available to the

Company or may not be available at acceptable conditions. Reference is also made to the related party disclosures in respect

of the mandatory prepayment obligations and limited recourse provisions under the Limited Recourse Loan Facility (to the

extent that these apply following the receipt of the proceeds of the exercise of the Put Option (see also at 2.2, 2.5.4 and 2.5.5

above)).

7. Important events which occurred after the end of the financial year

There have been no significant events which occurred after the end of the financial year except those included in section 8

below.

8. Information regarding the circumstances that could materially affect the development of the Company

8.1. The EGM of 9 December 2019 and subsequent events

As described above, at 9 December 2019, an EGM was held to deliberate on the continuation of the Company's activities

and a proposed capital decrease. The shareholders' meeting rejected the continuation of the Company's activities. The

shareholders' meeting also rejected the proposed capital reduction, as a result of which it was not carried out. The Board

of Directors of the Company had taken the necessary measures to prepare the necessary reports with its statutory auditor

and had convened a new EGM to formally consider a proposal for liquidation. Such EGM was first scheduled to be held

on 25 March 2020 but had to be postponed due to the Covid-19 outbreak and corresponding restrictions that had been

introduced in Europe. The Company re-convened such EGM on 30 April 2020 for 2 June 2020 and, if the required

attendance quorum would not be met, 30 June 2020.

Certain shareholders initiated summary proceedings before the court of Antwerp to request the court to order that the

decision on the dissolution of the Company, following the 9 December 2019 EGM, be postponed (i) until three months

after a final report will have been issued by a panel of experts whose appointment is requested in separate proceedings

before the court, or, alternatively (ii) until three months after a final decision will have been rendered in the aforementioned

proceedings regarding the appointment of a panel of experts.

On 26 June 2020, the court of Antwerp dismissed the minority shareholders' claim for a postponement until three months

after a final report will have been issued by a panel of experts whose appointment is requested. However, the court did

Free English translation for information purposes only

accept their claim for a postponement of the decision on the dissolution of the Company until three months after a final

decision (i.e. a decision that will have obtained "res judicata effect") will have been rendered in the proceedings regarding

the appointment of a panel of experts. Consequently, in compliance with the 26 June 2020 court order, the (second) EGM

planned for 30 June 2020 having the resolutions regarding the proposal for dissolution of the Company on the agenda

was postponed.

As announced on 14 February 2023, in light of the announcement in the press that certain shareholders of the Company

would file a Supreme Court appeal against the judgment of the Antwerp Court of Appeal dated 17 November 2022 with

respect to the claim for the appointment of a panel of experts (which appeal has meanwhile been dismissed by judgment

dated 2 May 2024), the Company was of the opinion that it was not opportune to carry out its obligation to place the

dissolution on the agenda pending the Supreme Court appeal. The Company thus announced that it would not take steps

to convene a general meeting with dissolution as an agenda item (or take preparatory actions to that effect) until the

Supreme Court’s judgment, and that it would update the market by then. On 2 May 2024, the Supreme Court rejected

the shareholders’ appeal. The Company announced the same day that it would not submit the dissolution or the

continuation of the Company to the general meeting at that time and that it would revert to this matter no sooner than

after a decision by the Antwerp Enterprise Court (Turnhout division) on the petition for interim measures filed by a group

of minority shareholders on 11 March 2024. Following the decision of 9 January 2025 by the Antwerp Commercial Court

(Turnhout division) to postpone the assessment on the merits of the petition for interim measures, the Company

announced on 6 February 2025 that it did not deem it in the best interest of the Company at this stage to submit the

dissolution or the continuation of the Company to the general meeting of shareholders and that it would assess whether

this position is to be reconsidered in the corporate interest of the Company, including if and when there are any further

developments.

The delayed decision on the proposal for dissolution or continuation of the Company and, if applicable, the appointment

of a liquidator may negatively impact the Company's liquidity position as the Company continues to incur running costs

and costs in respect of the legal proceedings mentioned above and below. If the appointment of the liquidator is further

delayed beyond what is currently expected or not approved by the shareholders' meeting or if the costs are higher than

currently expected, the Company may need to secure additional funding. There is a risk that such additional funding may

not be available to the Company or may not be available at acceptable conditions.

8.2. Proceedings on the merits against, among others, Nyrstar and some of its current and former directors

On 29 May 2020, a group of shareholders summoned Nyrstar and some of its current directors as well as the Company’s

former auditor, Deloitte, to appear before the Antwerp Commercial Court, Turnhout Division. This writ of summons was

corrected on a number of points by a new writ of summons on 9 November 2020.

Nyrstar learned that, around the same time, the same group of shareholders had also issued writs of summons against

certain former directors of Nyrstar and against Trafigura PTE Ltd. and Trafigura Group PTE Ltd. (the “Trafigura

Companies”).

In their writs of summons, the plaintiff shareholders bring, among others, the following claims:

• a minority claim on behalf of Nyrstar for alleged shortcomings in the director’s management and breaches of

the Belgian Code of Companies and Associations (“BCCA”) and Nyrstar’s Articles of Association. This

minority claim is a derivative action in which any proceeds would accrue to Nyrstar (and not to the plaintiff

shareholders). In particular, the plaintiffs claim that the defendant directors, Deloitte and the Trafigura

Companies should be ordered jointly and severally to pay damages to Nyrstar, estimated in the (corrected)

summons to be at least EUR 1.2 billion. Nyrstar understands that the plaintiff shareholders today estimate the

alleged damages to be at least EUR 2 billion;

• a direct liability claim against, among others, certain current and former directors for errors which (allegedly)

caused individual damages to the plaintiff shareholders. On this basis, the plaintiffs are seeking personal

damages, provisionally estimated at EUR 1;

• a claim against Nyrstar for the reimbursement of costs incurred by the plaintiff shareholders which are not

reimbursed by the other defendants.

The handling of these claims was postponed for an indefinite period immediately after the introductory hearing on 18

November 2020 (at the request of the plaintiff shareholders), with the exception of the proceedings against the Trafigura

Companies, where submissions have been exchanged between the latter and the plaintiff shareholders. Nyrstar

understands that the group of plaintiff shareholders has, in these submissions, filed a claim against the Trafigura

Companies for annulment of certain transactions since 2015.

By interlocutory judgment dated 26 July 2022, the Antwerp Commercial Court, Turnhout division, joined the proceedings

against the Trafigura Companies with the proceedings against some of the current and former directors of Nyrstar, as

well as Deloitte. Subsequently, on 27 February 2023, thirteen new plaintiff shareholders voluntarily intervened in these

Free English translation for information purposes only

proceedings (which, for the remainder, remain postponed for an indefinite period at the request of the plaintiff

shareholders).

On 22 January 2024, Deloitte submitted a trial brief in these proceedings. In this brief, Deloitte demands that the actions

of the plaintiff shareholders be dismissed as inadmissible, or at least as unfounded, and that the plaintiff shareholders be

ordered to pay the legal costs. In subordinate order, Deloitte requests that Nyrstar and the directors involved in these

proceedings be ordered jointly and severally, in solidum, or one in the absence of the other to indemnify Deloitte for all

convictions (including interest and costs) it would incur against the plaintiff shareholders.

Nyrstar notes that neither the liability claims nor the claim for annulment have been filed against Nyrstar. Nyrstar formally

contests the plaintiff shareholders’ allegations in respect of the Company and will address these in the proceedings on

the merits.

8.3. Request for interim measures in the framework of the proceedings on the merits

On 11 March 2024, the plaintiff shareholders filed a motion for interim measures on the basis of art. 19, (3) of the Judicial

Code. They filed this motion in the framework of the (joined) proceedings on the merits pending before the Antwerp

Commercial Court, Turnhout division, against Nyrstar, certain current and former directors, the Trafigura Companies and

Deloitte. The plaintiff shareholders requested the Court to grant the following interim measures, as amended in their

submissions of 30 August 2024:

• To appoint a provisional administrator in the Company (or, in subordinate order, an ad hoc trustee), for a

period of 12 months, with the possibility of extension, at least until a final decision is rendered in the

proceedings on the merits, with the assignment to provisionally take over all tasks of management and

administration in the broadest sense;

• To order Nyrstar and the involved directors to fully cooperate with the provisional administrator (or ad hoc

trustee) subject to penalty payments;

• To order Nyrstar to advance the costs of the provisional administrator or ad hoc trustee; and

• The immediate suspension of the enforceability of all, or at least part, of the obligations under the Limited

Recourse Loan Facility entered into between the Company and NN2 Newco Limited, until a final decision is

rendered in the proceedings on the merits and at least for the entire duration of the mandate of the provisional

administrator or ad hoc trustee.

The plaintiff shareholders requested the Court to only decide on the request for interim measures, and to further postpone

any further decision on the remainder of the case.

The request for interim measures was discussed at the introductory hearing of 25 April 2024. The pleadings were held

on 28 November 2024. The Company contests the allegations of the plaintiff shareholders and therefore defended its

position in the proceedings regarding the interim measures.

By judgment of 9 January 2025, the Antwerp Commercial Court, Turnhout division has declared the request for the

appointment of a provisional administrator or ad hoc trustee admissible but decided to postpone the assessment on the

merits of such request. The Court established that there are currently no indications that the Company’s board of directors

is not functioning properly, and noted that a procedure before the Sanctions Committee of the FSMA is currently pending,

as well as a criminal investigation. In view thereof, the Court postponed the assessment on the merits of the request for

the appointment of a provisional administrator or ad hoc trustee until after a ruling by both the FSMA Sanctions Committee

as well as the Council Chamber or the Indictment Chamber. The Court therefore adjourned the request for an indefinite

period.

8.4. Investigation by the FSMA and proceedings before its Sanctions Committee regarding disclosure by Nyrstar

In September 2019, the Management Committee of the FSMA decided to launch an investigation into Nyrstar’s

disclosures. The FSMA itself has communicated about this investigation on multiple occasions:

• Initially, the FSMA investigation focused on the information disclosed on the commercial relationship with Trafigura.

However, in a press release dated 29 May 2020, the FSMA announced that the investigation was expanded to

include two additional elements: the information disclosed (i) on the expected profit contribution from the

redevelopment of the Australian Port Pirie smelter and the total cost of this project, and (ii) on Nyrstar’s solvency

and liquidity position at the end of 2018.

• In a press release dated 25 July 2022, the FSMA provided an update on the investigation. Among others, the

FSMA stated that the auditor had prepared a provisional report.

• In a press release dated 30 September 2022, the FSMA announced that, after deliberating on the auditor’s final

report, the FSMA’s Management Committee had decided to initiate proceedings against Nyrstar before the FSMA’s

Free English translation for information purposes only

Sanctions Committee, which may result in the imposition of an administrative fine. It is for the Sanctions Committee

to decide whether an infringement has occurred and to decide on the possible imposition of an administrative fine.

The FSMA’s press release also explained which grievances the Management Committee had retained with respect

to Nyrstar and explained that the Management Committee had forwarded the notification of grievances to the Public

Prosecutor of the Antwerp district (see below). Finally, the press release stated that the Management Committee

had asked the auditor to prepare an additional report on the possible application of an administrative fine to each of

the directors (or their permanent representatives) of Nyrstar in office at the time of the facts.

Nyrstar confirms that, on 30 September 2022, the FSMA’s Management Committee notified it of the grievances, provided

it with the auditor’s final investigation report and consequently referred the case to the Sanctions Committee.

Meanwhile, the FSMA’s Management Committee also referred the case against the directors of Nyrstar who were in

office at the time of the facts, to the Sanctions Committee. The Sanctions Committee then merged that case with the

case against Nyrstar and accordingly determined a calendar.

Nyrstar believes that it has at all times disclosed the required information in accordance with the relevant financial

regulations and legislation and defends this position in the proceedings before the Sanctions Committee. It will not

comment any further on the content of these ongoing proceedings, given their confidential nature. The hearings before

the FSMA’s Sanctions Committee have been concluded.

8.5. Criminal investigations

Nyrstar is aware of the following judicial investigations.

In 2019, a judicial investigation was initiated in Brussels after several individuals had filed a civil party complaint. In a

decision dated 1 October 2024, the council chamber of the French-speaking court of first instance in Brussels decided to

dismiss the Company from prosecution in this investigation. An appeal was filed against this decision. By judgment of 5

March 2025, the indictment chamber of the French-speaking Brussels court of appeal confirmed the ruling of the council

chamber and dismissed the Company from prosecution. The indictment chamber ruled that there were no reasons to

refer the criminal file to the investigating judge of the judicial investigation in Antwerp, as the civil parties had requested.

It confirmed that the investigation has, at no point, produced sufficient grounds to bring Nyrstar before a criminal court,

and that this concerns a corporate law dispute between shareholders, which falls under the jurisdiction of the commercial

court. The chamber also did not see how Nyrstar could have gained any advantage from the contested actions. The

chamber was critical for the criminal law policy of the Belgian State, in particular for the lack of capacity to carry out

(additional) investigative measures. The Chamber had noted that, also in this case, not all additional investigative

measures granted by the investigative judge had been carried out. Because the chamber considers the Belgian State to

have been negligent in this matter as a result of its criminal policy and the situation to be manifestly unreasonable, it

ordered the civil party who had filed a complaint initially to pay only a symbolic procedural compensation of 1 EUR to

Nyrstar. The Court did not order the other civil party involved in appeal to pay a procedural compensation as its complaint

had not started the criminal investigation. The Company was informed that no Supreme Court appeal was launched

against the judgment of the indictment chamber, which is therefore final.

In 2020, a judicial investigation was initiated in Mechelen.

In 2022, an investigation was initiated by the Public Prosecutor's Office in Antwerp, which was later closed. A judicial

investigation is also ongoing in Antwerp, in the framework of which a search took place

In a decision dated 24 October 2024, the council chamber of the court of first instance in Mechelen decided

to discharge the investigating judge in Mechelen of the criminal investigation into Nyrstar NV, with a view to transferring

the criminal file to the investigating judge of the judicial investigation in Antwerp. No appeal has been filed against this

decision. The judicial investigation in Mechelen is therefore transferred to Antwerp.

The Company cooperates fully and faithfully in respect of any (judicial) investigation. It will not comment any further on

the content or status thereof.

9. Branches

The Company has no branches.

10. Research and development

Until 31 July 2019, the Group undertook research and development through a number of activities at various production sites

of the Group. This research and development was primarily concentrated on the production of various high margin non-

Free English translation for information purposes only

commodity grade alloy products and by-products in Nyrstar’s Metals Processing operations. Following the completion of the

Restructuring at 31 July 2019, the Company does not undertake any research or development.

11. Information provided in accordance with Articles 7:220 and 7:203 of the Belgian Code of Companies and

Associations

The Company held no Company’s shares as at 31 December 2024 and 2023.

Issued shares

2024

2023

Shares outstanding

109,873,001

Treasury shares

As at 31 Dec

109,873,001

Movement in shares outstanding

2024

2023

As at 1 Jan

109,873,001

Capital increase

Employee shared based payment plan

As at 31 Dec

109,873,001

12. Information provided in accordance with Articles 7:96 and 7:97 of the Belgian Code of Companies and

Assocations

12.1. Article 7:96 of the Belgian Code of Companies and Associations

Directors are expected to arrange their personal and business affairs so as to avoid conflicts of interest with the Company.

Any director with a conflicting financial interest (as contemplated by article 7:96 of the Belgian Code of Companies and

Associations) on any matter before the Board of Directors must bring it to the attention of both the statutory auditor and fellow

directors, and take no part in any deliberations or voting related thereto. Section 1.4 of the Corporate Governance Charter

sets out the procedure for transactions between Nyrstar and the directors which are not covered by the legal provisions on

conflicts of interest.

During the financial year ending on 31 December 2024, one (1) situation occurred at a meeting of the Board of Directors which

fell within the scope of article 7:96 BCCA. During its meeting on 17 July 2024, the Board of Directors applied the procedure of

article 7:96 BCCA with respect to a decision on the remuneration of the special committee director members:

“Before the deliberations on this agenda item commence, Mr. Marc Taeymans declares he is directly conflicted as it also

concerns his remuneration in his capacity as member of the FSMA Special Committee and the Merits Special Committee. The

Company Secretary notes that the other directly conflicted director for the agenda item is Ms. Jane Moriarty as it concerns her

remuneration in her capacity as a member of the FSMA Special Committee. It is further noted by the Company Secretary that

Ms. Moriarty is not present at the board meeting and will therefore not take any part in the deliberations on this agenda item.

Mr. Marc Taeymans advises that due to his direct conflict, he will leave the meeting at this point in time before the deliberation

of the agenda item. The Company Secretary notes that Mr. Taeymans left the Board meeting at 14.10 CEST.

It was noted by the Company Secretary that the Nomination and Remuneration Committee had met on 12 July 2024 to discuss

the remuneration of special committee director members. The Nomination and Remuneration Committee unanimously

recommended that the Board of Directors approve a one-off payment of EUR 5,000 for each of the directors currently on the

Free English translation for information purposes only

FSMA Special Committee (i.e. Ms. Jane Moriarty and Mr. Marc Taeymans) and a one-off payment of EUR 10,000 for the

single director currently on the Merits Special Committee (i.e. Mr. Marc Taeymans). The one-off payments would be to

compensate the directors for their extra responsibilities and time commitments since the commencement of both the Special

Committees and future work up until the end of 2024. The Nomination and Remuneration Committee would again assess in

2025 whether additional compensation would be required for work undertaken and to be undertaken by the director members

in 2025. For the avoidance of doubt, it was noted that there would not be any additional remuneration paid to the Company’s

two consultant managers (i.e. the Company Secretary and CFO) for their membership of the two special committees.

The non-conflicted members of the Board resolved unanimously to approve the additional remuneration for Ms. Jane Moriarty

and Mr. Marc Taeymans. It was noted by the Company Secretary and CFO that they would provide instructions to the

Company’s accountants to action the one-off payment based on the Board’s approval.”

12.2. Article 7:97 of the Belgian Code of Companies and Associations

When decisions or transactions are taken by the Company involving its related parties within the meaning of IAS 24, such

decisions and transactions are subject to the decision-making procedure set out in article 7:97 of the Belgian Code of

Companies and Associations.

No decisions or transactions have taken place during the financial year ending on 31 December 2024 that fell within the scope

of article 7:97 of the Belgian Code of Companies and Associations.

13. Information provided in accordance with article 34 of the Royal Decree dated 14 November 2007

The elements that need to be provided in accordance with article 34 of the Royal Decree dated 14 November 2007 to the

extent that these elements could have consequences in the event of a public takeover bid are discussed in detail in the

corporate governance statement as attached to this report as annex B.

14. Audit committee

The Audit Committee consists of at least three directors. All members of the Audit Committee are non-executive directors.

According to the Belgian Code of Companies and Associations, all members of the Audit Committee must be non-executive

directors, and at least one member must be independent within the meaning of the Belgian Code on Corporate Governance.

The members of the Audit Committee at 31 December 2024 were Anne Fahy (Chairman), Jane Moriarty, Carole Cable and

Marc Taeymans. The current composition of the Audit Committee complies with the Belgian Code of Companies and

Associations. For the justification of the independence and accounting and audit expertise of the members of the Audit

Committee, reference is made to the Corporate Governance Statement of the Company.

The members of the Audit Committee must have a collective competence in the business activities of the Company as well as

accounting, auditing and finance. The current Chair of the Audit Committee is competent in accounting and auditing as

evidenced by her previous role as Chief Financial Officer of BP’s Aviation Fuels business. According to the Board of Directors,

the other members of the Audit Committee also satisfy this requirement, as evidenced by the different senior management

and director mandates that they have held in the past and currently hold (see also “—Other mandates” in the Corporate

Governance Statement).

The assignments of the Audit Committee can vary according to the circumstances. However, the Audit Committee mainly has

the following duties (article 7:99 §4 BCCA):

• informing the Board of Directors of the result of the audit of the annual accounts of the Company and explain how the

audit has contributed to the integrity of the financial reporting and what role the Audit Committee played in that process;

• monitoring the financial overall reporting process, and submit recommendations or proposals to ensure its integrity;

Free English translation for information purposes only

• monitoring the effectiveness of the Company's overall internal control processes and risk management systems and, if

an internal audit function exists, monitoring the Company's internal audit function and its effectiveness;

• monitoring the statutory audit of the annual accounts, including follow-up on questions and recommendations made by

the statutory auditor;

• reviewing and monitoring the independence of the statutory auditor, in particular, if applicable, regarding the provision of

additional non-audit services to the Company; and

• be responsible for the procedure for the selection of the statutory auditor in accordance with the law and make a motivated

recommendation to the Board of Directors as to the nomination or renewal of the mandate of the statutory auditor.

The Audit Committee regularly reports to the Board of Directors on the exercise of its missions, including when preparing the

annual accounts.

In principle, the Audit Committee meets as frequently as necessary for the efficiency of the operation of the Audit Committee,

but at least two times a year.

15. Discharge

The Board of Directors requests the shareholders of the Company to approve the statutory financial statements attached

hereto and to grant discharge to the directors of the Company and to the statutory auditor for the exercise of their mandate

during this financial year of the Company.

* * *

Free English translation for information purposes only

Brussels, 17 April 2025.

On behalf of the Board of Directors,

___________________________

Martyn Konig

Director

Anne Fahy

Director

Annex A: Statutory financial statements of Nyrstar NV for the year ended 31 December 2024

Annex B: Statement of responsibility of Nyrstar NV for the year ended 31 December 2024

Annex C: Corporate governance statement in accordance with article 3:6 §2 of Belgian Code of Companies and

Associations

Annex D: Remuneration Report in accordance with article 3:6 §3 of Belgian Code of Companies and Associations

Annex A

Statutory financial statements of Nyrstar NV for the year ended 31 December 2024

[Separate document]

Annex B

Statement of responsibility of Nyrstar NV for the year ended 31 December 2024

The undersigned, Martyn Konig, Chairman of the Board of Directors, and Anne Fahy, Director, declare that, to the best of

their knowledge:

a. the statutory financial statements for the year ended 31 December 2024 which have been prepared in accordance with

Belgian Code of Companies and Associations give a true and fair view of the assets, the financial position and income

statement of the issuer;

b. the annual report for the statutory financial statements for the year ended 31 December 2024 which has been prepared

in accordance with the Belgian Code of Companies and Associations gives a true and fair view of the development and

results of the company and of the position of the company, as well as a description of the main risks and uncertainties

with which it is confronted.

Brussels, 17 April 2025

Martyn Konig Anne Fahy

Chairman of the Board of Directors Director

Annex C

Corporate governance statement in accordance with article 3:6 §2 of Belgian Code of Companies and Associations

[Separate document]

Annex D

Remuneration Report in accordance with article 3:6 §3 of Belgian Code of Companies and Associations

[Separate document]

NAME:

Legal form :

Address:

N°.

Postal code: Town:

Country:

Website :

Company registration number

0888728945

DATE

10/07/2020

of filing the most recent document mentioning the date of publication of

the deed of incorporation and of the deed of amendment of the articles of association.

approved by the general meeting of

24/06/2025

the financial year covering the period from

1/01/2024 31/12/2024

1/01/2023 31/12/2023

The amounts for the preceding period are not

ANNUAL ACCOUNTS AND OTHER DOCUMENTS TO BE FILED IN

ACCORDANCE WITH THE BELGIAN COMPANIES AND ASSOCIATIONS

CODE

Public limited liability company

Belgium

Nyrstar

Zinkstraat

2490 Balen

are

Antwerpen, Division Turnhout

identical to the ones previously published.

IDENTIFICATION DETAILS (at the filing date)

EURO (2 decimals)

the ANNUAL ACCOUNTS in

Total number of pages filed: Numbers of the sections of the standard model form not filed

because they serve no useful purpose:

Signature

(name and position)

Signature

(name and position)

6.1, 6.2.1, 6.2.2, 6.2.3, 6.2.4, 6.2.5, 6.3.1, 6.3.2, 6.3.3, 6.3.4, 6.3.5, 6.3.6, 6.4.1, 6.4.2, 6.4.3, 6.5.1,

6.5.2, 6.17, 6.18.2, 7, 8, 9, 11, 12, 13, 14, 15

Martyn Konig

Director

Anne Fahy

Director

F-cap 1

E-mail address :

This filing concerns :

the OTHER DOCUMENTS

regarding

the preceding period of the annual accounts from

Nyrstar

Where appropriate, “in liquidation” is stated after the legal form.

Optional mention.

1/43

Tick the appropriate box(es).

If necessary, change to currency in which the amounts are expressed.

Strike out what does not apply.

COMPLETE LIST with surname, first names, profession, place of residence (address, number, postal code and town) and position

within the company

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS AND

DECLARATION REGARDING A COMPLIMENTARY REVIEW OR

CORRECTION ASSIGNMENT

LIST OF DIRECTORS, BUSINESS MANAGERS AND AUDITORS

N°.

0888728945

F-cap 2.1

Fahy Anne

Zinkstraat 1, 2490 Balen, Belgium

Mandate: Director, start: 26/06/2024, end: 27/06/2028

Cable Carole

Zinkstraat 1, 2490 Balen, Belgium

Mandate: Director, start: 29/06/2021, end: 24/06/2025

Moriarty Jane

Zinkstraat 1, 2490 Balen, Belgium

Mandate: Director, start: 27/06/2023, end: 29/06/2027

Konig Martyn

Zinkstraat 1, 2490 Balen, Belgium

Mandate: President of the board of directors, start: 27/06/2023, end: 29/06/2027

Taeymans Marc

Zinkstraat 1, 2490 Balen, Belgium

Mandate: Director, start: 27/06/2023, end: 29/06/2027

BDO Bedrijfsrevisoren BV 0431.088.289

Membership number: B00023

Vincilaan 9, box E.6, 1930 Zaventem, Belgium

Mandate: Auditor, start: 27/06/2023, end: 30/06/2026

Represented by:

Claes Gert

, Membership number : A01775

Da Vincilaan 9 , box E.6 1930 Zaventem Belgium

2/43

N°.

0888728945

F-cap 2.2

DECLARATION REGARDING A COMPLIMENTARY REVIEW OR CORRECTION ASSIGNMENT

The managing board declares that not a single audit or correction assignment has been given to a person not authorized to do so by law,

pursuant to article 5 of the law of 17 March 2019 concerning the professions of accountant and tax advisor.

If affirmative, should be mentioned hereafter: surname, first names, profession and address of each certified accountant or company auditor

and their membership number at their Institute, as well as the nature of their assignment:

A. Bookkeeping of the company **,

B. Preparing the annual accounts **,

C. Auditing the annual accounts and/or

D. Correcting the annual accounts.

The annual accounts

were

were not

* audited or corrected by a certified accountant or by a company auditor who is not the statutory

If the tasks mentioned under A or B are executed by accountants or fiscal accountants, the following information can be mentioned

hereafter: surname, first names, profession and address of each accountant or fiscal accountant and their membership number at the

Institute of Accountants and Tax advisors, as well as the nature of their assignment.

auditor.

Membership number

Nature of the

assignment

(A, B, C and/or D)

Surname, first names, profession and address

* Strike out what does not apply.

** Optional mention.

3/43

N°.

0888728945

F-cap 3.1

BALANCE SHEET AFTER APPROPRIATION

Codes Period Preceding period

ASSETS

Tangible fixed assets

FIXED ASSETS

Intangible fixed assets

FORMATION EXPENSES

Land and buildings

Plant, machinery and equipment

Furniture and vehicles

Leasing and other similar rights

Other tangible fixed assets

Assets under construction and advance payments

Financial fixed assets

6.3

6.2

6.4 /

6.5.1

21/28

22/27

Notes

ANNUAL ACCOUNTS

6.1

Affiliated Companies

Participating interests

Amounts receivable

Other companies linked by participating interests

Participating interests

Amounts receivable

Other financial fixed assets

Amounts receivable and cash guarantees

6.15

280/1

280

281

282/3

282

283

284/8

284

285/8

4/43

N°.

0888728945

F-cap 3.1

Codes Period Preceding period

CURRENT ASSETS

Amounts receivable after more than one year

Trade debtors

Other amounts receivable

Stocks and contracts in progress

Stocks

Raw materials and consumables

Work in progress

Finished goods

Goods purchased for resale

Immovable property intended for sale

Advance payments

Contracts in progress

Amounts receivable within one year

Trade debtors

Other amounts receivable

Current investments

Own shares

Other investments

Cash at bank and in hand

Accruals and deferred income

TOTAL ASSETS

6.5.1 /

6.6

13.343.148,97

550.534,66

11.000.000,00

1.520.289,03

272.325,28

13.343.148,97

16.211.966,96

321.505,95

13.000.000,00

1.915.376,70

975.084,31

16.211.966,96

29/58

290

291

30/36

30/31

40/41

50/53

51/53

54/58

490/1

20/58

Notes

5/43

N°.

0888728945

F-cap 3.2

Codes Period Preceding period

EQUITY AND LIABILITIES

Reserves

EQUITY

Contributions

Issued capital

Uncalled capital

Legal reserve

Financial support

Other

Accumulated profits (losses)

Deferred taxes

(+)/(-)

Untaxed reserves

Available reserves

Capital subsidies

Advance to shareholders on the distribution of net

assets

PROVISIONS AND DEFERRED TAXES

Provisions for liabilities and charges

1.330.530.636,44

114.134.760,97

-1.355.219.642,31

10/15

10/11

100

101

130

1319

1313

132

160/5

Revaluation surpluses

133

168

10.744.967,68

-3.960.901,78

1.330.530.636,44

114.134.760,97

16.257.028,06

-1.350.748.566,28

9.396.097,76

-8.431.977,81

16.257.028,06

Notes

Pensions and similar obligations 160

Taxes 161

Major repairs and maintenance 162

Environmental obligations 163

Other liabilities and charges 10.744.967,68164/5 9.396.097,76

6.7.1

6.8

Capital 10 114.134.760,97 114.134.760,97

Beyond capital

Share premium account

Other

1100/10

1109/19

1.216.395.875,47

1.216.395.875,47 1.216.395.875,47

1.216.395.875,47

Reserves not available

Reserves not available statutorily

Purchase of own shares

130/1

1311

1312

6/43

Amount to be deducted from the issued capital.

Amount to be deducted from the other components of equity.

N°.

0888728945

F-cap 3.2

Codes Period Preceding period

AMOUNTS PAYABLE

Amounts payable after more than one year

Financial debts

Advance payments on contracts in progress

Current portion of amounts payable after more than

one year falling due within one year

Taxes

Other amounts payable

Accruals and deferred income

TOTAL LIABILITIES

Remuneration and social security

Other amounts payable

Amounts payable within one year

Financial debts

Credit institutions

Other loans

Trade debts

Suppliers

Bills of exchange payable

Advance payments on contracts in progress

Taxes, remuneration and social security

17/49

176

178/9

42/48

430/8

439

440/4

441

450/3

454/9

47/48

492/3

10/49

11.030.159,10

10.850.267,58

10.485.695,27

343.007,49

21.564,82

16.564,82

5.000,00

179.891,52

13.343.148,97 16.211.966,96

10.776.770,98

10.598.442,27

10.059.138,49

500.974,31

38.329,47

16.316,83

22.012,64

178.328,71

Notes

170/4

343.007,49

6.9

Subordinated loans

Unsubordinated debentures

Leasing and other similar obligations

Credit institutions

Other loans

Trade debts

Suppliers

Bills of exchange payable

170

171

172

173

174

175

1750

1751

7/43

N°.

0888728945

F-cap 4

PROFIT AND LOSS ACCOUNT

Codes Period Preceding period

Operating charges

Operating income

Turnover

Produced fixed assets

Other operating income

Goods for resale, raw materials and consumables

Purchases

Stocks: decrease (increase)

Services and other goods

Remuneration, social security and pensions

Amounts written down on stocks, contracts in progress

and trade debtors: additions (write-backs)

Other operating charges

Operating charges reported as assets under

restructuring costs

Operating profit (loss)

6.10

Stocks of finished goods and work and contracts

in progress: increase (decrease)

6.10

Amortisations of and other amounts written down on

formation expenses, intangible and tangible fixed

assets

6.10

Provisions for liabilities and charges: appropriations (uses

and write-backs)

6.10

1.889.047,80

35.051,83

6.389.890,77

5.039.935,33

1.085,52

-4.500.842,97

3.584.339,22

33.025,32

5.060.102,39

5.070.617,88

1.252,19

-1.475.763,17

70/76A

630

60/66A

600/8

609

631/4

635/8

640/8

649

9901

Notes

Non-recurring operating income

76A

1.853.995,97 3.551.313,90

6.12

-5.230,08 -11.767,68

Non-recurring operating charges

1.354.100,0066A 6.12

6.10

(+)/(-)

(-)

8/43

N°.

0888728945

F-cap 4

Codes Period Preceding period

Taxes

Adjustment of income taxes and write-back of tax

provisions

Profit (Loss) for the period before taxes

Profit (Loss) of the period

Transfer from deferred taxes

Transfer to deferred taxes

Income taxes on the result

6.13

Transfer from untaxed reserves

Transfer to untaxed reserves

Profit (Loss) of the period available for appropriation

-4.471.076,03

-1.463.565,09

-1.463.565,099905

689

780

680

67/77

670/3

9904

789

9903

Notes

Income from financial fixed assets

Income from current assets

Financial income

Debt charges

Amounts written down on current assets other than

stocks, contracts in progress and trade debtors:

additions (write-backs)

Other financial charges

Other financial income 6.11

Financial charges

6.11

460.891,66

175,10

3.180,23

428.119,59

386.510,00

125,76

367.698,70

6.738,98

75/76B

750

751

752/9

65/66B

650

651

652/9

461.066,76 386.635,76

431.299,82 374.437,68

386.635,76Recurring financial income 75 461.066,76

Non-recurring financial income 76B

374.437,68Recurring financial charges 65 431.299,82

Non-recurring financial charges 66B

6.12

(+)/(-)

9/43

N°.

0888728945

F-cap 5

Codes Period Preceding period

APPROPRIATION ACCOUNT

Profit (Loss) of the period available for appropriation

to contributions

Employees

to legal reserve

Compensation for contributions

Directors or managers

Transfers from equity

Appropriations to equity

Profit (loss) to be carried forward

Shareholders' contribution in respect of losses

Profit to be distributed

Profit (Loss) to be appropriated

Profit (Loss) of the preceding period brought forward

to other reserves

-1.355.219.642,31

-4.471.076,03

-1.350.748.566,28

-1.355.219.642,31

-1.350.748.566,28

-1.463.565,09

-1.349.285.001,19

-1.350.748.566,28

9906

(9905)

14P

791/2

691/2

6921

(14)

794

6920

694

696

695

694/7

691

Other beneficiaries 697

from contributions

from reserves

791

792

(+)/(-)

10/43

N°.

0888728945

F-cap 6.6

CURRENT INVESTMENTS AND ACCRUALS AND DEFERRED INCOME

Codes Period Preceding period

Shares – Book value increased with the uncalled amount

With a remaining term or notice

Shares and investments other than fixed income investments

Fixed-income securities

Fixed income securities issued by credit institutions

CURRENT INVESTMENTS - OTHER INVESTMENTS

Shares – Uncalled amount

Term accounts with credit institutions

up to one month

over one year

between one month and one year

Other investments not mentioned above

11.000.000,00

13.000.000,00

8681

8682

8684

8686

8687

8688

8689

Precious metals and works of art 8683

Allocation of account 490/1 of assets if the amount is significant

ACCRUALS AND DEFERRED INCOME

Period

Insurance fees 120.766,77

External serrvices - consultants 577,75

Telephone/cummunication 16.305,53

Laywers' and related fees not reimbursed by insurance 43.454,10

Membership deductible 2.083,34

Interest income 28.147,79

Audit fees BDO

60.990,00

11/43

N°. F-cap 6.7.1

0888728945

STATEMENT OF CAPITAL

Capital

Codes Period Preceding period

Issued capital at the end of the period

100P

(100)

XXXXXXXXXXXXXX 114.134.760,97

114.134.760,97

STATEMENT OF CAPITAL AND SHAREHOLDERS’ STURCTURE

Codes Period Number of shares

Modifications during the period

Composition of the capital

Share types

114.134.760,97 109.873.001Ordinary shares without par value

8702

8703

XXXXXXXXXXXXXX

102.443.567

7.429.434

XXXXXXXXXXXXXX

Registered shares

Shares dematerialized

Uncalled amount Called up amount, unpaid

Unpaid capital

Codes

Uncalled capital

Called up capital, unpaid

(101)

8712

XXXXXXXXXXXXXX

Shareholders that still need to pay up in full

Own shares

Period

Held by the company itself

Amount of capital held

Number of shares

Held by a subsidiary

Codes

8722

8731

8732

8721

Amount of capital held

Number of shares

Commitments to issuing shares

Owing to the exercise of conversion rights

Amount of outstanding convertible loans

Amount of capital to be subscribed

8741

8740

Corresponding maximum number of shares to be issued 8742

Owing to the exercise of subscription rights

Number of outstanding subscription rights

8746

8745

8747

Authorised capital not issued

8751

Amount of capital to be subscribed

Corresponding maximum number of shares to be issued

12/43

N°. F-cap 6.7.1

0888728945

Shares issued, non-representing capital

Period

Distribution

Number of shares

Number of voting rights attached thereto

Allocation by shareholder

Number of shares held by the company itself

Number of shares held by its subsidiaries

Codes

8762

8771

8781

8761

Period

ADDITIONAL NOTES REGARDING CONTRIBUTIONS (INCLUDING CONTRIBUTIONS IN THE FORM OF

SERVICES OR KNOW-HOW)

13/43

N°.

0888728945

F-cap 6.7.2

SHAREHOLDERS' STRUCTURE OF THE COMPANY AT YEAR-END CLOSING DATE

As reflected in the notifications received by the company pursuant to article 7:225 of the Belgian Companies and Associations Code, article

14 fourth paragraph of the law of 2 May 2007 on the publication of major holdings and article 5 of the Royal Decree of 21 August 2008 on

further rules for certain multilateral trading facilities.

14/43

N°.

0888728945

F-cap 6.8

PROVISIONS FOR OTHER LIABILITIES AND CHARGES

Period

ALLOCATION OF ACCOUNT 164/5 OF LIABILITIES IF THE AMOUNT IS SIGNIFICANT

Provision for discontinuation 10.733.200,00

Other provisions 11.767,68

15/43

N°.

0888728945

F-cap 6.9

Codes Period

STATEMENT OF AMOUNTS PAYABLE AND ACCRUALS AND DEFERRED INCOME (LIABILITIES)

Leasing and other similar obligations

Advance payments on contracts in progress

Other loans

Suppliers

Bills of exchange payable

Total current portion of amounts payable after more than one year falling due within one year

Trade debts

Amounts payable with a remaining term of more than one year, yet less than 5 years

Financial debts

Subordinated loans

Unsubordinated debentures

Total amounts payable with a remaining term of more than one year, yet less than 5 years

Amounts payable with a remaining term of more than 5 years

BREAKDOWN OF AMOUNTS PAYABLE WITH AN ORIGINAL TERM OF MORE THAN

ONE YEAR, ACCORDING TO THEIR RESIDUAL MATURITY

Current portion of amounts payable after more than one year falling due within one year

Credit institutions

Other amounts payable

Amounts payable with a remaining term of more than 5 years

8811

8821

8831

8841

8801

8851

8861

8871

8881

8891

(42)

8901

8802

8812

8822

8832

8842

8852

8862

8872

8882

8892

8902

8912

8803

8813

8823

8833

8843

8853

8863

8873

8883

8893

8903

8913

Leasing and other similar obligations

Advance payments on contracts in progress

Other loans

Suppliers

Bills of exchange payable

Trade debts

Financial debts

Subordinated loans

Unsubordinated debentures

Credit institutions

Other amounts payable

Leasing and other similar obligations

Advance payments on contracts in progress

Other loans

Suppliers

Bills of exchange payable

Trade debts

Financial debts

Subordinated loans

Unsubordinated debentures

Credit institutions

Other amounts payable

16/43

N°.

0888728945

F-cap 6.9

Codes Period

Total of the amounts payable guaranteed by the Belgian government agencies

Amounts payable guaranteed by real securities given or irrevocably promised by the

company on its own assets

Taxes

AMOUNTS PAYABLE GUARANTEED

Amounts payable guaranteed by the Belgian government agencies

(included in accounts 17 and 42/48 of liabilities)

Remuneration and social security

Total amounts payable guaranteed by real securities given or irrevocably promised by the

company on its own assets

TAXES, REMUNERATION AND SOCIAL SECURITY

(headings 450/3 and 178/9 of liabilities)

Outstanding tax debts

Accruing taxes payable

Estimated taxes payable

Remuneration and social security

(headings 454/9 and 178/9 of liabilities)

Amounts due to the National Social Security Office

Other amounts payable in respect of remuneration and social security

16.564,82

5.000,00

8931

8941

8951

8961

8921

8971

8981

8991

9001

9011

9051

9021

9061

8922

8932

8942

8952

8962

8972

8982

8992

9002

9022

9062

9012

9072

9073

450

9076

9077

9052

Taxes

Remuneration and social security 9042

9032

Leasing and other similar obligations

Advance payments on contracts in progress

Other loans

Suppliers

Bills of exchange payable

Trade debts

Financial debts

Subordinated loans

Unsubordinated debentures

Credit institutions

Other amounts payable

Taxes, remuneration and social security

Leasing and other similar obligations

Advance payments on contracts in progress

Other loans

Suppliers

Bills of exchange payable

Trade debts

Financial debts

Subordinated loans

Unsubordinated debentures

Credit institutions

Other amounts payable

Codes Period

17/43

N°.

0888728945

F-cap 6.9

Period

Allocation of heading 492/3 of liabilities if the amount is significant

ACCRUALS AND DEFERRED INCOME

TR accrued intrest payable 179.891,52

18/43

N°.

0888728945

F-cap 6.10

Codes Period Preceding period

OPERATING RESULTS

OPERATING INCOME

Net turnover

Allocation by categories of activity

Allocation by geographical market

Operating subsidies and compensatory amounts received from

public authorities

740

Other operating income

OPERATING CHARGES

Employees for whom the company submitted a DIMONA declaration or

who are recorded in the general personnel register

Total number at the closing date

Average number of employees calculated in full-time equivalents

Number of actual hours worked 9088

9087

9086

Remuneration and direct social benefits

Employers' contribution for social security

Personnel costs

Employers' premiums for extra statutory insurance

Other personnel costs

Retirement and survivors' pensions

620

621

622

623

624

Appropriations (uses and write-backs)

On stock and contracts in progress

Provisions for pensions and similar obligations

Recorded

Written back

Depreciations

On trade debtors

635

9110

9111

9112

9113

Recorded

Written back

Codes Period Preceding period

Other

Provisions for liabilities and charges

Appropriations

Uses and write-backs

Other operating charges

Taxes related to operation

5.230,08 11.767,68

118,00

967,52

283,93

968,26

9115

9116

640

641/8

Hired temporary staff and personnel placed at the company’s

disposal

Costs to the company

9096

9097

9098

617

Total number at the closing date

Average number calculated in full-time equivalents

Number of actual hours worked

(+)/(-)

19/43

N°.

0888728945

F-cap 6.11

FINANCIAL RESULTS

Codes Period Preceding period

Other financial income

RECURRING FINANCIAL INCOME

Subsidies paid by public authorities, added to the profit and loss account

Capital subsidies

Interest subsidies 9126

9125

Allocation of other financial income

Exchange differences realized 754

Other

positive foreign exchange differences 175,10 125,76

RECURRING FINANCIAL CHARGES

Depreciation of loan issue expenses

Depreciations on current assets

Amount of the discount borne by the company, as a result of negotiating

amounts receivable

Appropriations

Uses and write-backs

Provisions of a financial nature

Other financial charges

Recorded

Written back

Capitalised interests

6502

6501

6511

6510

6561

6560

653

Allocation of other financial costs

Exchange differences realized

Results from the conversion of foreign currencies

654

655

Other

Negative foreign exchange differences 1.163,56 4.112,27

20/43

N°.

0888728945

F-cap 6.12

INCOME AND CHARGES OF EXCEPTIONAL SIZE OR FREQUENCY

Codes Period Preceding period

NON-RECURRING INCOME

Write-back of depreciation and of amounts written off intangible and

tangible fixed assets

Write-back of provisions for extraordinary operating liabilities and

charges

Capital profits on disposal of intangible and tangible fixed assets

1.853.995,97 3.551.313,90

1.443.200,00

760

7620

7630

Non-recurring operating income

1.853.995,97 3.551.313,90(76A)

Other non-recurring operating income 1.853.995,97 2.108.113,90764/8

Write-back of amounts written down financial fixed assets

Write-back of provisions for extraordinary financial liabilities and

charges

Capital profits on disposal of financial fixed assets

761

7621

7631

Non-recurring financial income

(76B)

Other non-recurring financial income 769

NON-RECURRING CHARGES

Non-recurring depreciation of and amounts written off formation

expenses, intangible and tangible fixed assets

Provisions for extraordinary operating liabilities and charges:

appropriations (uses)

Capital losses on disposal of intangible and tangible fixed assets

1.354.100,00

660

6620

6630

Non-recurring operating charges

1.354.100,00(66A)

Other non-recurring operating charges 664/7

Amounts written off financial fixed assets

Provisions for extraordinary financial liabilities and charges -

appropriations (uses)

Capital losses on disposal of financial fixed assets

661

6621

6631

Non-recurring financial charges

(66B)

Other non-recurring financial charges 668

Non-recurring operating charges carried to assets as restructuring

costs

6690

Non-recurring financial charges carried to assets as restructuring

costs

6691

(+)/(-)

(-)

21/43

N°.

0888728945

F-cap 6.13

TAXES

PeriodCodes

INCOME TAXES

Income taxes on the result of the period

Income taxes paid and withholding taxes due or paid

Income taxes on the result of prior periods

Additional income taxes due or paid

Excess of income tax prepayments and withholding taxes paid recorded under assets

Estimated additional taxes

Additional income taxes estimated or provided for

138.267,49

9135

9134

9137

9136

9139

9138

9140

Major reasons for the differences between pre-tax profit, as it results from the annual accounts,

and estimated taxable profit

Influence of non-recurring results on income taxes on the result of the period

Period

Sources of deferred taxes

PeriodCodes

Deferred taxes representing assets

Accumulated tax losses deductible from future taxable profits

332.998.113,12

228.901.295,239142

9141

Other deferred taxes representing assets

DBI 104.096.817,89

9144Deferred taxes representing liabilities

Allocation of deferred taxes representing liabilities

Codes Period Preceding period

VALUE-ADDED TAXES AND TAXES BORNE BY THIRD PARTIES

Value-added taxes charged

To the company (deductible)

By the company

Amounts withheld on behalf of third party by way of

Payroll withholding taxes

Withholding taxes on investment income

911.982,91

187.610,89

863.420,75

229.957,409146

9145

9148

9147

22/43

N°.

0888728945

F-cap 6.14

RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET

Codes Period

PERSONAL GUARANTEES PROVIDED OR IRREVOCABLY PROMISED BY THE COMPANY AS

SECURITY FOR DEBTS AND COMMITMENTS OF THIRD PARTIES

Of which

Real guarantees provided or irrevocably promised by the company on its own assets as security

of debts and commitments of the company

Amount of registration

Mortgages

Book value of the immovable properties mortgaged

Bills of exchange in circulation endorsed by the company

REAL GUARANTEES

Maximum amount up to which the debt is secured and which is the subject of

registration

For irrevocable mandates to pledge goodwill, the amount for which the agent can take the

inscription

9150

9149

91611

91721

91621

91711

Bills of exchange in circulation drawn or guaranteed by the company 9151

Maximum amount for which other debts or commitments of third parties are guaranteed by the

company

9153

For irrevocable mortgage mandates, the amount for which the agent can take

registration

91631

Pledging of goodwill

Pledging of other assets or irrevocable mandates to pledge other assets

Book value of the immovable properties mortgaged

Maximum amount up to which the debt is secured

91811

91821

Guarantees provided or irrevocably promised on future assets

Amount of assets in question

Maximum amount up to which the debt is secured

91911

91921

Vendor’s privilege

Book value of sold goods

Amount of the unpaid price

92011

92021

23/43

N°.

0888728945

F-cap 6.14

Real guarantees provided or irrevocably promised by the company on its own assets as security

of debts and commitments of third parties

Amount of registration

Mortgages

Book value of the immovable properties mortgaged

Maximum amount up to which the debt is secured and which is the subject of registration

For irrevocable mandates to pledge goodwill, the amount for which the agent can take the

inscription

91612

91722

91622

91712

For irrevocable mortgage mandates, the amount for which the agent can take

registration

91632

Pledging of goodwill

Pledging of other assets or irrevocable mandates to pledge other assets

Book value of the immovable properties mortgaged

Maximum amount up to which the debt is secured

91812

91822

Guarantees provided or irrevocably promised on future assets

Amount of assets in question

Maximum amount up to which the debt is secured

91912

91922

Vendor’s privilege

Book value of sold goods

Amount of the unpaid price

92012

92022

Codes Period

GOODS AND VALUES, NOT REFLECTED IN THE BALANCE SHEET, HELD BY THIRD PARTIES IN

THEIR OWN NAME BUT FOR THE BENEFIT AND AT THE RISK OF THE COMPANY

Codes Period

SUBSTANTIAL COMMITMENTS TO ACQUIRE FIXED ASSETS

SUBSTANTIAL COMMITMENTS TO DISPOSE OF FIXED ASSETS

Goods purchased (to be received)

FORWARD TRANSACTIONS

9213

Goods sold (to be delivered)

9214

Currencies purchased (to be received)

9215

Currencies sold (to be delivered)

9216

Period

COMMITMENTS RELATING TO TECHNICAL GUARANTEES IN RESPECT OF SALES OR SERVICES

Period

AMOUNT, NATURE AND FORM CONCERNING LITIGATION AND OTHER IMPORTANT COMMITMENTS

24/43

N°.

0888728945

F-cap 6.14

SETTLEMENT REGARDING THE COMPLEMENTARY RETIREMENT OR SURVIVORS’ PENSION FOR PERSONNEL AND BOARD

MEMBERS

Brief description

Measures taken to cover the related charges

Code Period

PENSIONS FUNDED BY THE COMPANY ITSELF

Methods of estimation

9220

Estimated amount of the commitments resulting from past services

Period

NATURE AND FINANCIAL IMPACT OF SIGNIFICANT EVENTS AFTER THE CLOSING DATE not reflected in

the balance sheet or income statement

Refer to VOL 6.20

Period

COMMITMENTS TO PURCHASE OR SALE AVAILABLE TO THE COMPANY AS ISSUER OF OPTIONS FOR

SALE OR PURCHASE

Period

NATURE, COMMERCIAL OBJECTIVE AND FINANCIAL CONSEQUENCES OF TRANSACTIONS NOT

REFLECTED IN THE BALANCE SHEET

If the risks and benefits resulting from such transactions are of any meaning and if publishing such risks

and benefits is necessary to appreciate the financial situation of the company

Period

OTHER RIGHTS AND COMMITMENTS NOT REFLECTED IN THE BALANCE SHEET (including those that

cannot be calculated)

Until 31 July 2019, the Company was the holding company of the Nyrstar group (consisting of the Company

and its former subsidiaries). At 31 July 2019, when the Restructuring of the Nyrstar group was finalised, the

Company was released of liabilities for

for existing financial indebtedness and obligations owed under parentcompany guarantees of commercial or

other obligations of the current members of the Operating Group (all former subsidiaries of the Nyrstar group

excluding NN1) (or indemnified by NN2 to

the extent suchgarantuee liabilities are not released). As at 31 December 2024, based on information

available to the Company, the Company has been fully released from all contingent liabiliteis previously

provided orirrevocably promised by the Company

debts and commitments of third parties. The Company is fully indemnified in relation to any liability that may

arise in this respect see "Related party disclosures").

25/43

N°.

0888728945

F-cap 6.15

RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES

LINKED BY PARTICIPATING INTERESTS

Codes Period Preceding period

AFFILIATED COMPANIES

Participating interests

Provided or irrevocably promised by affiliated companies as security for

debts or commitments of the company

Subordinated amounts receivable

Financial fixed assets

Other amounts receivable

Amounts receivable

Over one year

Within one year

Current investments

Amounts receivable

Amounts payable

Personal and real guarantees

Provided or irrevocably promised by the company as security for debts or

commitments of affiliated companies

Other significant financial commitments

Financial results

Income from financial fixed assets

Income from current assets

Other financial income

Debt charges

Other financial charges

Disposal of fixed assets

Capital profits realised

Capital losses realised

(280/1)

(280)

9271

9281

9291

9301

9311

9321

9331

9351

9341

9361

9371

9381

9391

9401

9421

9431

9441

9461

9471

9481

9491

Over one year

Within one year

26/43

N°.

0888728945

F-cap 6.15

RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES

LINKED BY PARTICIPATING INTERESTS

Codes Period Preceding period

ASSOCIATED COMPANIES

Participating interests

COMPANIES LINKED BY PARTICIPATING INTERESTS

Provided or irrevocably promised by affiliated companies as security for

debts or commitments of the company

Subordinated amounts receivable

Financial fixed assets

Other amounts receivable

Amounts receivable

Over one year

Within one year

Amounts payable

Over one year

Within one year

Personal and real guarantees

Provided or irrevocably promised by the company as security for debts or

commitments of affiliated companies

Other significant financial commitments

Financial fixed assets

9253

9263

9273

9283

9293

9303

9313

9353

9363

9373

9383

9393

9403

9262

9252

Participating interests

Amounts receivable

Amounts payable

9362

9372

9272

9282

9292

9302

9352

9312

Subordinated amounts receivable

Other amounts receivable

Over one year

Within one year

Over one year

Within one year

27/43

N°.

0888728945

F-cap 6.15

RELATIONSHIPS WITH AFFILIATED COMPANIES, ASSOCIATED COMPANIES AND OTHER COMPANIES

LINKED BY PARTICIPATING INTERESTS

Period

TRANSACTIONS WITH AFFILIATED PARTIES BEYOND NORMAL MARKET CONDITIONS

Mention of these transactions if they are significant, including the amount of the transactions, the nature

of the link, and all information about the transactions that should be necessary to get a better

understanding of the financial situation of the company

The relationship with Trafigura, including the outstanding balances as at 31 December 2024 and the

interestcharges on the LRLF incurred during the year ended on 31 December 2024 are further disclosed in C

6.20.

28/43

N°.

0888728945

F-cap 6.16

FINANCIAL RELATIONSHIPS WITH

PeriodCodes

DIRECTORS AND MANAGERS, INDIVIDUALS OR LEGAL PERSONS WHO CONTROL

THE COMPANY DIRECTLY OR INDIRECTLY WITHOUT BEING ASSOCIATED

THEREWITH, OR OTHER COMPANIES CONTROLLED DIRECTLY OR INDIRECTLY BY

THESE PERSONS

Amounts receivable from these persons

9500

Principal conditions regarding amounts receivable, rate of interest, duration, any amounts repaid,

cancelled or written off

Guarantees provided in their favour

9501

Other significant commitments undertaken in their favour

9502

Amount of direct and indirect remunerations and pensions, reflected in the income statement, as

long as this disclosure does not concern exclusively or mainly, the situation of a single

identifiable person

To directors and managers

To former directors and former managers

598.363,96

9504

9503

Codes Period

THE AUDITOR(S) AND THE PERSONS WHOM HE (THEY) IS (ARE) COLLABORATING

WITH

Auditors' fees

Fees for exceptional services or special assignments executed within the company by the auditor

Other audit assignments

Tax consultancy assignments

Other assignments beyondthe audit

159.605,009505

95061

95062

95063

Fees for exceptional services or special assignments executed within the company by people the

auditor(s) is (are collaborating with

95081

95082

95083

Other audit assignments

Tax consultancy assignments

Other assignments beyond the audit

Mentions related to article 3:64, § 2 and § 4 of the Belgian Companies and Associations Code

29/43

N°.

0888728945

F-cap 6.18.1

DECLARATION WITH REGARD TO THE CONSOLIDATED ANNUAL ACCOUNTS

INFORMATION TO DISCLOSE BY EACH COMPANY GOVERNED BY THE BELGIAN COMPANIES AND ASSOCIATIONS

CODE ON THE CONSOLIDATED ANNUAL ACCOUNTS

The company has prepared and published consolidated annual accounts and a consolidated annual report*

The company has not prepared consolidated annual accounts and a consolidated annual report, because of an exemption

for the following reason(s)*

The company and its subsidiaries exceed, on a consolidated basis, not more than one of the criteria mentioned in article 1:26 of

the Belgian Companies and Associations Code*

The company itself is a subsidiary of a parent company that prepares and publishes consolidated annual accounts, in which the

annual accounts are integrated by consolidation*

The company only has subsidiaries that, considering the evaluation of the consolidated capital, the consolidated financial position

or the consolidated result, individually or together, are of negligible interestError! Bookmark not defined. (article 3:23 of the Belgian

Companies and Associations Code)

Name, full address of the registered office and, if it concerns companies under Belgian law, the company registration number of

the parent company(ies) and the indication if this (these) parent company(ies) prepares (prepare) and publishes (publish)

consolidated annual accounts, in which the annual accounts are included by means of consolidation**:

If the parent company(ies) is (are) (a) company(ies) governed by foreign law, the location where the abovementioned annual accounts

are available**:

* Strike out what does not apply.

** Where the annual accounts of the company are consolidated at different levels, the information should be given, on the one hand at the

highest and on the other at the lowest level of companies of which the company is a subsidiary and for which consolidated accounts

are prepared and published.

30/43

N°.

0888728945

F-cap 6.19

VALUATION RULES

Valuation rules Nyrstar NV (hereafter "the Company")

General:

The valuation rules are drafted in accordance with the statements of the Royal Decree dd. 29 April 2019 implementing the Belgian Code

of Companies and Associations, relating to valuation rules. As a consequence of the Restructuring (as defined below) and the outcomes

of the 9 December 2019 Extraordinary Shareholders Meeting ("EGM"), where the shareholders' meeting rejected the continuation of the

Company's activities, the 31 December 2024 financial statements of the Company are prepared on a discontinuity basis. For further

information on the outcomes of the Restructuring, please refer to "Related party disclosures".

Valuation rules applied to the Company's balance sheet prepared on a discontinuity basis include:

I.Financial fixed assets Participations are accounted for at the lower of realisation values and historical purchase cost.

II.Current assets and liabilities

Current assets, which include input VAT on ongoing expenses for which the Company either received or expects to receive refund from

the relevant authorities, and current liabilities are recognised at their realisation values. At 31 December 2024, the realization values equal

nominal values. Current assets and liabilities denominated in foreign currencies are valued at the closing rates on the end of the financial

year. The negative (unrealized) exchange rate differences are accounted for in the income statement. Based on the principle of prudence,

the positive, unrealized exchange rate differences at balance sheet date are accounted for as deferred income on the balance sheet.

III.Provisions for liabilities and charges

A provision is recognized to reflect liabilities and charges, resulting from a past event for which the nature is clearly defined, is considered

probable or certain at balance sheet date, but for which the amount is uncertain. Provisions resulting from prior accounting years are

regularly reviewed and are reversed if they are no longer required or the risks and charges are realized.

IV.Income statement

The income statement reflects all revenue realized and expenses incurred during the accounting period on an accrual basis, regardless of

the date on which these expenses and income are paid or collected.

Adjustments recorded with respect to the valuation and the classification of certain balance sheet items as a result of the Company

applying the discontinuity basis for the preparation of the 31 December 2024 financial statements:

a)The formation expenses were fully depreciated as required by Article 3:6 of the Royal Decree d.d. 29 April 2019 implementing the

Belgian Code of Companies and Associations.

b)Explanation on determination of expected probable realization value in accordance with Article 3:6 of the Royal Decree d.d. 29 April

2019 implementing the Belgian Code of Companies and Associations.

Before 28 July 2022, the Company had, in its current investments, a 2% equity stake in NN2 NewCo Limited ("NN2") as a consequence of

the issuance by NN2 of a 2% equity stake in NN2 to the Company with the remaining 98% equity stake issued to Nyrstar Holdings Plc (a

holding company within the Trafigura corporate group, formerly known as Nyrstar Holdings Limited). The Company also had a Put Option

(as defined below) enabling it to sell all (but not a part only) of its 2% stake in NN2 to a Trafigura entity at a price equal to EUR 20 million

in aggregate payable to the Company. As announced by the Company on 28 July 2022, this Put Option was exercised by the Company

on 28 July 2022 (see Related Party disclosures - 1.2 below) and on 29 July 2022, the Company duly received the EUR 20 million Put

Option price following such exercise. Reference is made in this respect to the related party disclosures in respect of the mandatory

prepayment obligations and limited recourse provisions under the Limited Recourse Loan Facility (to the extent that these apply following

the receipt of the proceeds of the exercise of the Put Option (see 1.5.4. and 1.5.5. below)).

c)The decision of the 9 December 2019 EGM not to continue the Company's activities resulted in the requirement for the Company to

recognize a provision for discontinuation representing the estimated costs that the Company expects to incur before the completion of the

liquidation. At 31 December 2024 the Company recognised a provision for discontinuation of EUR 10.7 million (31 December 2023: EUR

9.4 million) representing the estimated costs that the Company expects to incur before the completion of a liquidation process that is

assumed to be finalised before the end of Q3 2031 (31 December 2023: before the end of 2030). Potential additional litigation may result

in a further delay of this assumed date of completion of a liquidation process; the Company has at current no indication thereof.

The following legal and regulatory actions have been considered when determining the amount of the provision as at 31 December 2024.

The EGM of 9 December 2019 and the order of the President of the Antwerp Enterprise Court of 26 June 2020

As described above, at 9 December 2019, an EGM was held to deliberate on the continuation of the Company's activities and a proposed

capital decrease. The shareholders' meeting rejected the continuation of the Company's activities. The shareholders' meeting also

rejected the proposed capital reduction, as a result of which it was not carried out. The Board of Directors of the Company had taken the

necessary measures to prepare the necessary reports with its statutory auditor and had convened a new EGM to formally consider a

proposal for liquidation. Such EGM was first scheduled to be held on 25 March 2020 but had to be postponed due to the Covid-19

outbreak and corresponding restrictions that had been introduced in Europe. The Company re-convened such EGM on 30 April 2020 for 2

June 2020 and, if the required attendance quorum would not be met, 30 June 2020.

Certain shareholders initiated summary proceedings before the court of Antwerp to request the court to order that the decision on the

dissolution of the Company, following the 9 December 2019 EGM, be postponed (i) until three months after a final report will have been

issued by a panel of experts whose appointment is requested in separate proceedings before the court, or, alternatively (ii) until three

months after a final decision will have been rendered in the aforementioned proceedings regarding the appointment of a panel of experts.

On 26 June 2020, the court of Antwerp dismissed the minority shareholders' claim for a postponement until three months after a final

report will have been issued by a panel of experts whose appointment is requested. However, the court did accept their claim for a

postponement of the decision on the dissolution of the Company until three months after a final decision (i.e. a decision that will have

obtained "res judicata effect") will have been rendered in the proceedings regarding the appointment of a panel of experts. Consequently,

in compliance with the 26 June 2020 court order, the (second) EGM planned for 30 June 2020 having the resolutions regarding the

proposal for dissolution of the Company on the agenda was postponed.

31/43

N°.

0888728945

F-cap 6.19

VALUATION RULES

As announced on 14 February 2023, in light of the announcement in the press that certain shareholders of the Company would file a

Supreme Court appeal against the judgment of the Antwerp Court of Appeal dated 17 November 2022 with respect to the claim for the

appointment of a panel of experts (which appeal has meanwhile been dismissed by judgment dated 2 May 2024), the Company was of the

opinion that it was not opportune to carry out its obligation to place the dissolution on the agenda pending the Supreme Court appeal. The

Company thus announced that it would not take steps to convene a general meeting with dissolution as an agenda item (or take

preparatory actions to that effect) until the Supreme Court's judgment, and that it would update the market by then. On 2 May 2024, the

Company announced that it would not submit the dissolution or the continuation of the Company to the general meeting at that time and

that it would revert to this matter no sooner than after a decision by the Antwerp Enterprise Court (Turnhout division) on the petition for

interim measures filed by a group of minority shareholders on 11 March 2024. Following the decision of 9 January 2025 by the Antwerp

Commercial Court (Turnhout division) to postpone the assessment on the merits of the petition for interim measures, the Company

announced on 6 February 2025 that it did not deem it in the best interest of the Company at this stage to submit the dissolution or the

continuation of the Company to the general meeting of shareholders and that it would assess whether this position is to be reconsidered

in the corporate interest of the Company, including if and when there are any further developments.

The delayed decision on the proposal for dissolution or continuation of the Company and, if applicable, the appointment of a liquidator

may negatively impact the Company's liquidity position as the Company continues to incur running costs and costs in respect of the legal

proceedings mentioned above and below. If the appointment of the liquidator is further delayed beyond what is currently expected or not

approved by the shareholders' meeting or if the costs are higher than currently expected, the Company may need to secure additional

funding. There is a risk that such additional funding may not be available to the Company or may not be available at acceptable

conditions.

Proceedings on the merits against, among others, Nyrstar and some of its current and former directors

On 29 May 2020, a group of shareholders summoned Nyrstar and some of its current directors as well as the Company's former auditor,

Deloitte, to appear before the Antwerp Commercial Court, Turnhout Division. This writ of summons was corrected on a number of points

by a new writ of summons on 9 November 2020.

Nyrstar learned that, around the same time, the same group of shareholders had also issued writs of summons against certain former

directors of Nyrstar and against Trafigura PTE Ltd. and Trafigura Group PTE Ltd. (the "Trafigura Companies").

In their writs of summons, the plaintiff shareholders bring, among others, the following claims:

"a minority claim on behalf of Nyrstar for alleged shortcomings in the director's management and breaches of the Belgian Code of

Companies and Associations ("BCCA") and Nyrstar's Articles of Association. This minority claim is a derivative action in which any

proceeds would accrue to Nyrstar (and not to the plaintiff shareholders). In particular, the plaintiffs claim that the defendant directors,

Deloitte and the Trafigura Companies should be ordered jointly and severally to pay damages to Nyrstar, estimated in the (corrected)

summons to be at least EUR 1.2 billion. Nyrstar understands that the plaintiff shareholders today estimate the alleged damages to be at

least EUR 2 billion;

"a direct liability claim against, among others, certain current and former directors for errors which (allegedly) caused individual damages

to the plaintiff shareholders. On this basis, the plaintiffs are seeking personal damages, provisionally estimated at EUR 1;

"a claim against Nyrstar for the reimbursement of costs incurred by the plaintiff shareholders which are not reimbursed by the other

defendants.

The handling of these claims was postponed for an indefinite period immediately after the introductory hearing on 18 November 2020 (at

the request of the plaintiff shareholders), with the exception of the proceedings against the Trafigura Companies, where submissions have

been exchanged between the latter and the plaintiff shareholders. Nyrstar understands that the group of plaintiff shareholders has, in

these submissions, filed a claim against the Trafigura Companies for annulment of certain transactions since 2015.

By interlocutory judgment dated 26 July 2022, the Antwerp Commercial Court, Turnhout division, merged the proceedings against the

Trafigura Companies with the proceedings against some of the current and former directors of Nyrstar, as well as Deloitte. Subsequently,

on 27 February 2023, thirteen new plaintiff shareholders voluntarily intervened in these proceedings (which, for the remainder, remain

postponed for an indefinite period at the request of the plaintiff shareholders).

On 22 January 2024, Deloitte submitted a trial brief in these proceedings. In this brief, Deloitte demands that the actions of the plaintiff

shareholders be dismissed as inadmissible, or at least as unfounded, and that the plaintiff shareholders be ordered to pay the legal costs.

In subordinate order, Deloitte requests that Nyrstar and the directors involved in these proceedings be ordered jointly and severally, in

solidum, or one in the absence of the other to indemnify Deloitte for all convictions (including interest and costs) it would incur against the

plaintiff shareholders.

Nyrstar notes that neither the liability claims nor the claim for annulment have been filed against Nyrstar. Nyrstar formally contests the

plaintiff shareholders' allegations in respect of the company and will address these in the proceedings on the merits

Request for interim measures in the framework of the proceedings on the merits

On 11 March 2024, the plaintiff shareholders filed a motion for interim measures on the basis of art. 19, (3) of the Judicial Code. They filed

this motion in the framework of the proceedings on the merits pending before the Antwerp Commercial Court, Turnhout division, against

Nyrstar, certain current and former directors, the Trafigura Companies and Deloitte (as merged on 26 July 2022). The plaintiff

shareholders requested the Court to grant the following interim measures, as amended in their submissions of 30 August 2024:

"To appoint a provisional administrator in the Company (or, in subordinate order, an ad hoc trustee), for a period of 12 months, with the

possibility of extension, at least until a final decision is rendered in the proceedings on the merits, with the assignment to provisionally

take over all tasks of management and administration in the broadest sense;

"To order Nyrstar and the involved directors to fully cooperate with the provisional administrator (or ad hoc trustee) subject to penalty

payments;

"To order Nyrstar to advance the costs of the provisional administrator or ad hoc trustee; and

32/43

N°.

0888728945

F-cap 6.19

VALUATION RULES

"The immediate suspension of the enforceability of all, or at least part, of the obligations under the Limited Recourse Loan Facility entered

into between the Company and NN2 Newco Limited, until a final decision is rendered in the proceedings on the merits and at least for the

entire duration of the mandate of the provisional administrator or ad hoc trustee.

The plaintiff shareholders requested the Court to only decide on the request for interim measures, and to further postpone any further

decision on the remainder of the case.

By judgment of 9 January 2025, the Antwerp Commercial Court, Turnhout division has declared the request for the appointment of a

provisional administrator or ad hoc trustee admissible but decided to postpone the assessment on the merits of such request. The Court

established that there are currently no indications that the Company's board of directors is not functioning properly, and noted that a

procedure before the Sanctions Committee of the FSMA is currently pending, as well as a criminal investigation. In view thereof, the Court

postponed the assessment on the merits of the request for the appointment of a provisional administrator or ad hoc trustee until after a

ruling by both the FSMA Sanctions Committee as well as the Council Chamber or the Indictment Chamber. The Court therefore adjourned

the request for an indefinite period.

Investigation by the FSMA and proceedings before its Sanctions Committee regarding disclosure by Nyrstar

In September 2019, the Management Committee of the FSMA decided to launch an investigation into Nyrstar's disclosures. The FSMA

itself has communicated about this investigation on multiple occasions:

"Initially, the FSMA investigation focused on the information disclosed on the commercial relationship with Trafigura. However, in a press

release dated 29 May 2020, the FSMA announced that the investigation was expanded to include two additional elements: the information

disclosed (i) on the expected profit contribution from the redevelopment of the Australian Port Pirie smelter and the total cost of this

project, and (ii) on Nyrstar's solvency and liquidity position at the end of 2018.

"In a press release dated 25 July 2022, the FSMA provided an update on the investigation. Among others, the FSMA stated that the

auditor had prepared a provisional report.

"In a press release dated 30 September 2022, the FSMA announced that, after deliberating on the auditor's final report, the FSMA's

Management Committee had decided to initiate proceedings against Nyrstar before the FSMA's Sanctions Committee, which may result

in the imposition of an administrative fine. It is for the Sanctions Committee to decide whether an infringement has occurred and to decide

on the possible imposition of an administrative fine. The FSMA's press release also explained which grievances the Management

Committee had retained with respect to Nyrstar and explained that the Management Committee had forwarded the notification of

grievances to the Public Prosecutor of the Antwerp district (see below, under III.). Finally, the press release stated that the Management

Committee had asked the auditor to prepare an additional report on the possible application of an administrative fine to each of the

directors (or their permanent representatives) of Nyrstar in office at the time of the facts.

Nyrstar confirms that, on 30 September 2022, the FSMA's Management Committee notified it of the grievances, provided it with the

auditor's final investigation report and consequently referred the case to the Sanctions Committee.

Meanwhile, the FSMA's Management Committee also referred the case against the directors of Nyrstar who were in office at the time of

the facts, to the Sanctions Committee. The Sanctions Committee then merged that case with the case against Nyrstar and accordingly

determined a calendar.

Nyrstar believes that it has at all times disclosed the required information in accordance with the relevant financial regulations and

legislation and defends this position in the proceedings before the Sanctions Committee. The hearings before the FSMA's Sanctions

Committee have been concluded.

Nyrstar will not comment any further on the content of these proceedings, given their confidential nature.

Criminal investigations

Nyrstar is aware of the following judicial investigations.

In 2019, a judicial investigation was initiated in Brussels after several individuals had filed a civil party complaint. In a decision dated 1

October 2024, the council chamber of the French-speaking court of first instance in Brussels decided to dismiss the Company from

prosecution in this investigation. An appeal has been filed against this decision.

In 2020, a judicial investigation was initiated in Mechelen.

In 2022, an investigation was initiated by the Public Prosecutor's Office in Antwerp, which was later closed. A judicial investigation is also

ongoing in Antwerp.

In a decision dated 24 October 2024, the council chamber of the court of first instance in Mechelen decided to discharge the investigating

judge in Mechelen of the criminal investigation into Nyrstar NV, with a view to transferring the criminal file to the investigating judge of the

judicial investigation in Antwerp. No appeal has been filed against this decision. The judicial investigation in Mechelen is therefore

transferred to Antwerp.

The Company cooperates fully and faithfully in respect of any (judicial) investigation. It will not comment any further on the content or

status thereof.

In estimating the provision for discontinuation of EUR 10.7 million recognised at 31 December 2024 and taking into account the (pending)

legal proceedings referred to above (and on the basis of a reasonable expectation as to the timing of Belgian court proceedings), in

calculating the provision for discontinuation, the Company assumes the liquidation process to complete approximately by the end of Q3

2031, i.e. within approximately six and half years after the release of the 31 December 2024 financial statements. The amount of the

provision is based on the estimated operating costs to be incurred before and during the liquidation process. These costs include costs of

33/43

N°.

0888728945

F-cap 6.19

VALUATION RULES

the liquidator, legal, accounting and audit costs, listing fees and other operating costs. The estimated amount of the provision assumes a

stable run-rate of the cost of the liquidator and other costs to be incurred by the Company over the period until the completion of the

liquidation process.

The estimated amount of the provision excludes any costs that the Company may incur in relation to the defense in the legal proceedings

referred to above for which the Company's Directors & Officers ("D&O") insurer has at current confirmed to indemnify the Company for its

fees, costs and expenses incurred. The D&O insurer has at current only confirmed to indemnify the Company for its fees, costs and

expenses incurred in respect of:

(i)its counsel for assisting with the response to the notice of default dated 17 March 2020, and representing the Company in the civil

proceedings on the merits;

(ii)its counsel for representing the Company in the interlocutory (expert) proceedings issued on 27 April 2020, as well as the appeal lodged

by the Company on 15 December 2020 against the 30 October 2020 court order appointing an expert panel in the sense of Article 7:160

BCCA (and not, for the avoidance of doubt, the third party application initiated by the Trafigura Companies against the 30 October 2020

court order and the appeal against the court orders of 2 July and 9 November 2021), and the Supreme Court appeal;

(iii)its counsel for representing the Company in the (now terminated) expert investigation ordered by the aforementioned 30 October 2020

court order;

(iv)the party-appointed experts the Company has retained in order to research the claims made in the proceedings mentioned above as

well as to assist the Company in the expert investigation mentioned above; and

(v)its counsel for representing the Company regarding the FSMA investigation and the experts retained by the Company in respect of its

defense, for up to 80% of the work done as of 6 October 2022;

(vi)its counsel for representing the Company in the summary proceedings for interim measures initiated by certain shareholders on 3

January 2023.

However, the D&O insurer has refused coverage of the fees, costs and expenses of the court-appointed experts (as referred to above),

based on the court order of 30 October 2020 (against which the Company lodged appeal and against which Trafigura PTE Ltd. and

Trafigura Group PTE Ltd. lodged a third-party application, and which was as a result of the latter application revoked by the judgment of 9

November 2021 of the President of the Antwerp Enterprise Court (Antwerp division)), which have been covered by the Company.

Should the liquidation process take longer than expected, the estimated costs to be incurred by the Company before the completion of the

liquidation would be higher. Assuming the liquidation is in that case completed by the end of Q4 2033, the Company estimates the costs

incurred during the liquidation process would increase to EUR 13.4 million. These additional costs in excess of the provision of EUR 10.7

million recognised at 31 December 2024 would further decrease the equity of the Company subsequent to 31 December 2024. If there are

any additional costs or if the costs related to one or more legal proceedings noted above would not be covered by the Company's D&O

insurance, it may require the Company to obtain additional funding. In case the Company is unable to obtain such additional funding, the

liquidation may not be a solvent liquidation.

The Company has recognised the ongoing operating costs that it incurred during the year ended 31 December 2024 as Services and

other goods (Code 61). During the year ended 31 December 2024, the Company has utilised the provision for discontinuation of EUR 3.1

million, primarily to offset the ongoing operating costs. The utilisation of the provision is recognised in Non-recurring operating charges

(Code 66A) net of the additions to the provision for discontinuation of EUR 4.5 million.

d)As at 31 December 2024, based on the information available to the Company, the Company has been fully released from all contingent

liabilities previously provided or irrevocably promised by the Company for debts and commitments of third parties. The Company is fully

indemnified in relation to any liability that may arise in this respect (see "Related party disclosures").

The Company has assessed the potential impact of the war in Ukraine on the recognition and measurement of the Company's assets and

liabilities as at 31 December 2024. Following the exercise of the Put Option and the receipt of the proceeds of the exercise of the Put

Option, the Company's main assets are cash and cash term deposits. In the Company's view, there are no potential significant impacts of

the war in Ukraine on the measurement of the Company's assets and liabilities at 31 December 2024.

34/43

N°.

0888728945

F-cap 6.20

OTHER INFORMATION TO DISCLOSE

DISCONTINUITY

At 9 December 2019, an EGM of the Company was held to deliberate on the continuation of the Company's activities and a proposed

capital decrease. The shareholders' meeting rejected the continuation of the Company's activities. As the result of a decision of 26 June

2020 of the President of the Antwerp Enterprise Court (Antwerp division), given at the request of a group of shareholders, the Company

was prohibited from holding a general meeting with the dissolution of the Company on the agenda until three months after a final decision

on the appointment of a panel of experts would have obtained res judicata effect. As set out above, as announced on 14 February 2023, in

light of the announcement in the press that certain shareholders of the Company would file a Supreme Court appeal against the judgment

of the Antwerp Court of Appeal dated 17 November 2022 with respect to the claim for the appointment of a panel of experts (which appeal

has meanwhile been dismissed by judgment dated 2 May 2024), the Company was of the opinion that it was not opportune to carry out its

obligation to place the dissolution on the agenda pending the Supreme Court appeal. The Company thus announced that it would not take

steps to convene a general meeting with dissolution as an agenda item (or take preparatory actions to that effect) until the Supreme

Court's judgment, and that it would update the market by then.

On 2 May 2024, the Company announced that it would not submit the dissolution or the continuation of the Company to the general

meeting at that time and that it would revert to this matter no sooner than after a decision by the Antwerp Enterprise Court (Turnhout

division) on the petition for interim measures filed by a group of minority shareholders on 11 March 2024.

Following the decision of 9 January 2025 by the Antwerp Commercial Court (Turnhout division) to postpone the assessment on the merits

of the petition for interim measures filed by a group of shareholders on 11 March 2024, the Company announced on 6 February 2025 that

it did not deem it in the best interest of the Company at this stage to submit the dissolution or continuation of the Company to the general

meeting and that it would assess whether this position is to be reconsidered in the corporate interest of the Company, including if and

when there are any further developments.

As such, these 31 December 2024 financial statements of the Company have been prepared on a discontinuity basis.

Under article 3:23 of the Belgian Code of Companies and Associations, a parent company that controls one or more subsidiaries is

required to prepare consolidated financial statements, unless such subsidiaries are, in view of the consolidated assets, the consolidated

financial position or the consolidated results, individually and together, only of a negligible significance. Given that, as at 31 December

2024, the Company did not control any significant subsidiary, the Company was not required to prepare consolidated financial statements

for the year ended 31 December 2024. In accordance with article 12, §3, final paragraph, of the Royal Decree of 14 November 2007, the

Company has prepared the 31 December 2024 standalone half-year financial statements in accordance with Belgian GAAP.

At the date of authorisation of the 31 December 2024 financial statements, the Company has assessed that, taking into account its

available cash, cash equivalents and its cash flow projections for the next 12 months from the authorisation by the Board of Directors of

the 31 December 2024 financial statements, it has sufficient liquidity to meet its present obligations and cover working capital needs. The

forecast available liquidity of the Company comprises cash and cash term deposits of EUR 12.5 million as of 31 December 2024 and is

dependent on various matters including the possible appointment of a liquidator and his next steps, the existence and extent of the legal

claims against the Company which could require funding of these legal proceedings and other matters not currently foreseen as described

in section d) of the valuation rules above. As stated above, if the appointment of the liquidator is further delayed or not approved by the

shareholders' meeting or if the costs are higher than currently expected, the Company may need to secure additional funding. There is a

risk that such additional funding may not be available to the Company or may not be available at acceptable conditions. Reference is also

made to the related party disclosures in respect of the mandatory prepayment obligations and limited recourse provisions under the

Limited Recourse Loan Facility (to the extent that these apply following the receipt of the proceeds of the exercise of the Put Option (see

1.5.4. and 1.5.5. below)).

RELATED PARTY DISCLOSURES

1.Restructuring of the Nyrstar group

In October 2018, the former Nyrstar group initiated a review of its capital structure (the "Capital Structure Review") in response to the

challenging financial and operating conditions being faced by the Nyrstar group. The Capital Structure Review identified a very substantial

additional funding requirement that the Nyrstar group was unable to meet without a material reduction of its indebtedness. As a

consequence, the Capital Structure Review necessitated negotiations between the Nyrstar group's financial creditors that ultimately

resulted in the restructuring of the Nyrstar group, which became effective on 31 July 2019 (the "Restructuring"). As a result of the

Restructuring, Trafigura Group Pte. Ltd., via its indirect 98% ownership of the new holding company of NN2, became the ultimate parent

company of the former (direct and indirect) subsidiaries of the Company (the "Operating Group"), with the remaining 2% stake in NN2 (and

thereby the Operating Group) then being owned by the Company (though see 1.2 below for details of the exercise of the Put Option by the

Company on 28 July 2022).

The agreements with Trafigura to which the Company is a party are discussed in further detail below.

1.1.The NNV-Trafigura Deed

The lock-up agreement ("Lock Up Agreement") entered into on 14 April 2019 between, among others, the Company and representatives of

its key financial creditor groups, envisaged that the Company, Trafigura Pte Ltd ("Trafigura") and Nyrstar Holdings Plc (formerly known as

Nyrstar Holdings Limited, "Nyrstar Holdings"), a Trafigura special-purpose vehicle incorporated, amongst other things, for the purpose of

implementing the Restructuring) would enter into a deed confirming their agreement in respect of (i) certain steps necessary for the

implementation of the restructuring as envisaged in the Lock Up Agreement and (ii) the terms of the ongoing relationship between the

Company and the Trafigura group (the "NNV-Trafigura Deed"). The NNV-Trafigura Deed was duly executed on 19 June 2019.

Certain key terms of the NNV-Trafigura Deed, namely those governing the distributions policy, drag / tag rights and change of control in

respect of NN2, have previously been described in the Company's related party disclosures. However, following the exercise of the Put

Option (on which, see 1.2 below for more details) and the Company ceasing to be a shareholder of NN2, these provisions of the

NNV-Trafigura Deed are no longer relevant / no longer apply.

35/43

N°.

0888728945

F-cap 6.20

OTHER INFORMATION TO DISCLOSE

Under the provisions of the NNV-Trafigura Deed that do continue notwithstanding the exercise of the Put Option and the Company ceasing

to be a shareholder of NN2, the Company continues to benefit from a right (subject to compliance with applicable law and any relevant

confidentiality obligations) to make reasonable requests of Trafigura to procure that the Company is provided with financial or other

information in relation to the Operating Group (or any member of it).

1.2.The Put Option Deed

Pursuant to the NNV-Trafigura Deed, the Company and Trafigura also agreed that Trafigura would grant to the Company an option to

require a Trafigura entity to purchase the Company's entire interest in NN2. The terms of this option are set out in a separate deed, dated

25 June 2019, between the Company, Trafigura and Nyrstar Holdings (the "Put Option Deed"). Under the terms of the Put Option Deed,

the Company could put all (but not only a part) of its 2% holding in NN2 to a Trafigura entity at a price equal to EUR 20 million (the "Put

Option"). Reference is made in this respect to the related party disclosures in respect of the mandatory prepayment obligations and limited

recourse provisions under the Limited Recourse Loan Facility (to the extent that these apply following the receipt of the proceeds of the

exercise of the Put Option (see 1.5.4. and 1.5.5. below)). The Put Option was exercisable by the Company until 31 July 2022, subject to

limited triggers which would have allowed earlier termination of the Put Option before 31 July 2022.

On 18 November 2021, the Company announced that it had appointed Moore Corporate Finance to prepare an independent expert's

opinion for the independent directors of the Company ("Committee of Independent Directors"), in the framework of Article 7:97 of the

Belgian Code of Companies and Associations. The independent expert's opinion was to advise the Committee of Independent Directors in

examining the benefit to the Company, taking all relevant circumstances into account, of the exercise or non-exercise of the Put Option

that the Company had in relation to its entire 2% investment in NN2.

On 28 July 2022, the Company publicly announced that the Board had completed its detailed review process in respect of the decision

whether or not to exercise the Put Option related to its entire 2% shareholding in NN2. Considering the independent expert report prepared

by Moore Corporate Finance, which valued the 2% shareholding in NN2 in a range of EUR 0 million to EUR 3.4 million, the opinion of the

independent directors of the Company, questions and comments raised by certain minority shareholders and other information made

available to it, the Board decided that it was in the corporate benefit of the Company to exercise the Put Option. On 28 July 2022, the

Company duly gave notice to Nyrstar Holdings Plc and to Trafigura Pte Ltd. that it exercised the Put Option in accordance with the terms

of the Put Option Deed. The Company received the proceeds from the exercise of the Put Option on 29 July 2022. Documentation in

respect of the Company's decision to exercise the Put Option was published on the Company's website nyrstarnv.be on 28 July 2022 and

remains available there as at the date of this report.

1.3.Release from parent company guarantees in favour of Trafigura

As stated above, prior to the effective date of the Restructuring which was 31 July 2019 (the "Restructuring Effective Date"), the Company

was the ultimate parent company of the Nyrstar group, and had previously issued various parent company guarantees (the "PCGs") in

respect of the obligations of its subsidiaries, including, but not limited to, two PCGs granted in respect of the primary financial obligations

of the Company's indirect subsidiary at that time, Nyrstar Sales & Marketing AG ("NSM"), to Trafigura, namely under the USD 650 million

Trade Finance Framework Agreement ("TFFA") and the USD 250 million Bridge Finance Facility Agreement ("BFFA") (the "Trafigura

PCGs"). The Trafigura PCGs, as well as all other security and / or guarantees provided to Trafigura by the Operating Group in respect of

the TFFA and BFFA, were released in full on the Restructuring Effective Date.

1.4.The Company's release from parent company guarantees in favour of third-parties and the Company's rights to indemnification by NN2

under the NNV-NN2 SPA

Prior to, and as part of the implementation of, the Restructuring, the Company entered into an agreement for the sale and transfer by the

Company of substantially all of its assets including 100% of its shareholding in Nyrstar Netherlands (Holdings) BV and also its holdings

(direct and indirect) in its subsidiaries, but excluding its shares in NN1, to NN2 (the "NNV-NN2 SPA"). Under the NNV-NN2 SPA, the

Company benefits from contractual agreements with NN2 and Trafigura in respect of its release from, or indemnification for, liabilities for

existing financial indebtedness and obligations owed to third parties in respect of financial, commercial or other obligations of the then

current members of the Operating Group (the "PCGs"), such that those third parties should no longer have recourse to the Company. The

release and / or indemnification obligations of NN2 from which the Company benefits can be summarised as follows.

-Release of PCGs and general indemnity: The NNV-NN2 SPA includes a commitment by NN2 to use reasonable endeavors to procure the

release of obligations owed by the Company under third-party PCGs. This obligation is combined with an obligation on NN2 to indemnify

the Company, to the extent such PCGs are not released, for any and all liabilities in relation to such PCGs in respect of the failure by the

applicable member of the Operating Group to comply fully with its principal obligations.

-Indemnity for specified historic liabilities: Further, the NNV-NN2 SPA also contains an obligation on NN2 to indemnify the Company, to the

extent not covered by the release and/or indemnification of PCGs mentioned above, in respect of certain specified liabilities, including

certain liabilities arising in relation to certain historic disposals by the former Nyrstar group and/or from certain historic mine closures,

which are specified in a schedule to the NNV-NN2 SPA.

-Limitation on recourse to the Company of former subsidiaries: To limit and release further any financial obligations on the Company, the

NNV-NN2 SPA obliges NN2 to procure that, and the NNV-Trafigura Deed obliges Trafigura to procure that no former subsidiaries of the

Company will make any demands for payment from the Company except (i) under the Limited Recourse Loan Facility (as defined below),

(ii) as otherwise agreed following the completion of the Restructuring; or (iii) to the extent that the Company has sufficient funds available

(excluding any dividends or sale proceeds in respect of the Company's (now sold) direct 2% shareholding in NN2).

1.5.Financial transactions with Trafigura entities - the Limited Recourse Loan Facility 1.5.1.Introduction

On 23 July 2019, the Company entered into a EUR 13.5 million committed, limited recourse, loan facility (the "Limited Recourse Loan

Facility") provided to it by NN2 (as "Lender"). The key terms of the Limited Recourse Loan Facility are described below. The Limited

Recourse Loan Facility is made up of two separate tranches: (i) up to EUR 8.5 million to be applied towards the Company's ongoing

ordinary course operating activities ("Facility A"); and (ii) up to EUR 5 million intended for the payment of certain costs related to litigation

defense ("Facility B"). No security, collateral or guarantees have been granted in respect of the Company's obligations under the Limited

Recourse Loan Facility.

1.5.2.Expiry of the Availability Period, mounts outstanding and interest

The Availability Period of the LRLF, which applies to both Facility A and Facility B (described in more detail below), expired - in accordance

with its terms - at the end of July 2024 (being five years following the Restructuring Effective Date, i.e. five years from 31 July 2019), at

which point all unutilised commitments thereunder were immediately cancelled.

36/43

N°.

0888728945

F-cap 6.20

OTHER INFORMATION TO DISCLOSE

As at 31 December 2024, the Company owed EUR 6.6 million (31 December 2023: EUR 6.3 million) under Facility A. The purpose of

loans under Facility A is to be used by the Company to cover day-to-day operating costs, including, without limitation, reasonable director

and employee costs, D&O insurance premium (to the extent not paid prior to the Restructuring Effective Date), audit fees, legal costs

(except those relating to litigation or other actual or threatened proceedings against the Company, which should be funded from Facility B

(defined below)), listing fees and investor relations costs. Prior to the expiry of the Availability Period, the funding under Facility A was

provided to the Company based on the quarterly cash flow forecast prepared by the Company and provided to Trafigura as a condition of

the funding. Under Facility A, subject to the terms of utilisation, the Company could borrow up to EUR 8.5 million before 31 July 2024.The

total quantum of funds to be made available under Facility A was agreed based on the Company's forecast operating costs for a five-year

period following the completion of the Restructuring, taking into account the ongoing operational services provided to the Company by

NN2, as agreed in the NNV-NN2 SPA, for a period of approximately three years from the Restructuring Effective Date (the "Ongoing

Services").

The Ongoing Services included finance, tax, corporate counsel, IT and administration services. The provision of the Ongoing Services to

the Company was intended to reduce the Company's operating costs in the period following the Restructuring Effective Date. It is noted

here that, in accordance with the terms of the NNV-NN2 SPA, the period for the provision of the Ongoing Services to the Company expired

upon the Company's receipt of the proceeds from the exercise of the Put Option.

As at 31 December 2024, the Company owed EUR 3.9 million (31 December 2023: EUR 3.7 million) under Facility B. Subject to the

restrictions detailed below, the purpose of loans under Facility B is to be applied by the Company towards payment or reimbursement of

costs in respect of any litigation, proceeding, action or claims (including tax claims) made, asserted or threatened against the Company,

NN1 or any of their current or former directors or officers (each being a "Claim").

Prior to the expiry of the Availability Period, funding under Facility B could be drawn based on costs incurred in respect of any litigation,

proceeding, action or claims (subject to the terms of utilisation and other restrictions detailed below, and on the delivery of an invoice for

such costs). Utilisation of each Facility was subject to various conditions (on which see below), and was limited to a maximum of three

drawings per financial quarter per Facility (excluding any PIK Loans (defined below)). Under Facility B, subject to the terms of utilisation,

the Company could borrow up to EUR 5 million before 31 July 2024.

As at the date of this report, the Company owed EUR 6.6 million under Facility A and EUR 3.9 million under Facility B.

As a result of the exercise of the Put Option and the Company ceasing to be a shareholder of NN2, the "NNV Exit Date" (as defined in the

Limited Recourse Loan Facility) has occurred. The NNV Exit Date is specified as an Event of Default (as defined) under the Limited

Recourse Loan Facility, which gave the NN2 (as Lender) the right to cancel (by notice to the Company) the whole or any part of the

Lenders' remaining commitments under the Limited Recourse Loan Facility. NN2 has not exercised such right. However, in any event, and

as mentioned above, the Availability Period of the Limited Recourse Loan Facility expired in accordance with its terms at the end of July

2024, and all unutilised commitments thereunder were immediately cancelled at that time. As such, new utilisation requests of the Limited

Recourse Loan Facility can no longer validly be given.

The rate of interest on amounts outstanding under the Limited Recourse Loan Facility is the aggregate of EURIBOR plus a margin of 0.5%

per annum. It shall be payable within 10 business days of the anniversary of the date on which such amount was made available, provided

that such interest will be capitalised if it has accrued for a period of one year or more and the Company has given a notice in the form

prescribed by the Limited Recourse Loan Facility. Any interest which is capitalised shall be treated as a new loan (a "PIK Loan") under the

relevant Facility. Any PIK Loan shall itself accrue interest, and that interest may also be capitalised. No payments of interest have been

made by the Company as all payable interest until 31 December 2024 of EUR 753k has been capitalised into a new PIK Loan. The interest

charges on the Limited Recourse Loan Facility expensed in the Profit and Loss Account in the year ended 31 December 2024 were EUR

428k.

1.5.3.Restrictions on use of proceeds

The Company must not use any amount borrowed under either Facility A or Facility B for funding (directly or indirectly) any of the costs

related to asserting or bringing or assisting in the pursuit of claims (including any counterclaim or defense) against Trafigura, other

members of the Trafigura group, NN2 and / or any Replacement Holdco, and / or any other member of the Operating Group), against any

of such entities' current or former directors, officers, or advisers, against any creditor in respect of such entities (other than with the

consent of NN2, such consent not to be unreasonably withheld or delayed) or in connection with any challenge to the Restructuring,

including in relation to the TFFA and the BFFA or any other document contemplated by the Restructuring Implementation Deed.

1.5.4.Mandatory prepayment obligations

-Excess Cash: the provisions of the Limited Recourse Loan Facility that relate to mandatory prepayment out of "Excess Cash", and which

were described in the version of this disclosure contained in previous such reports by the Company, have ceased to apply as a result of

the Company ceasing to be a shareholder of NN2 and having received the proceeds of the exercise of the Put Option (such proceeds

constituting "Disposal Proceeds" for the purposes of the Limited Recourse Loan Facility).

-Disposals: Immediately upon receipt of any Disposal Proceeds, and subject to the limited recourse provisions described below (see in

particular at 1.5.5.), the Company shall procure that these shall be applied first to prepay any amount outstanding under Facility B (being

the litigation tranche), and secondly, if (i) any Disposal Proceeds remain after any required prepayment of Facility B, and (ii) the aggregate

amount of all amounts outstanding under Facility A (being the operational costs tranche) exceeds EUR 5 million, to prepay such Facility A

amounts to or towards an aggregate amount of EUR 5 million.

-Distributions: The Company shall ensure that, if any distribution is paid to the Company's shareholders on or after the NNV Exit Date, an

amount equal to that distribution is applied to repay or prepay the amount outstanding under Facility A before or simultaneously with such

distribution.

The Company has also agreed that, if it receives any amounts from costs awards, damages awards and / or any other recovery from any

counterparty to a Claim (as defined above) (such amounts constituting "Claim Proceeds"), then such Claim Proceeds must be used

immediately to repay or prepay any amounts outstanding under Facility B.

37/43

N°.

0888728945

F-cap 6.20

OTHER INFORMATION TO DISCLOSE

Additionally, there are customary provisions that require mandatory prepayment of amounts outstanding under either or both Facility A and

B in the case of certain events of default that allow for acceleration by the Lender.

However, in accordance with "limited recourse" provisions of the Limited Recourse Loan Facility (as detailed further at 1.5.5. below), NN2's

recourse to the Company in respect of repayment of funds drawn or any other obligation thereunder is limited to the Company's Net

Assets (as defined in the Limited Recourse Loan Facility, and as described below), if any.

1.5.5.Limited recourse

As mentioned above, the recourse of NN2 as Lender under the Limited Recourse Loan Facility in respect of repayment thereof or any

other obligation of the Company thereunder is limited to the "Company Net Assets", being the assets (including all present and future

properties, revenues and rights of every description) of the Company (other than assets held or received on trust for a person which is not

a member of the Company or its subsidiaries) having satisfied or provided for its "Liabilities" (meaning all present or future liabilities and

obligations, both actual and contingent and whether incurred solely or jointly or as principal or surety or in any other capacity), except for

Liabilities of the Company under the Limited Recourse Loan Facility and related finance documents, which shall be disregarded for this

purpose.

Further, to the extent that the Company Net Assets are insufficient to discharge the Company's obligations under the Limited Recourse

Loan Facility, such obligations shall be deemed to be limited to the amount of the Company Net Assets, and the Lender shall not be

entitled to make a claim and shall have no further recourse against the Company and the Company shall have no liability to pay or

otherwise.

All actual, contingent and prospective liabilities would need to be factored in when calculating the Company Net Asset position. The

Company determined at the time of the exercise of the Put Option on 28 July 2022 and as at 31 December 2024, that it is in the corporate

benefit of the Company that, for the purposes of the mandatory prepayment, these liabilities are calculated on a worst-case scenario basis,

and not (i) in accordance with IFRS or Belgian GAAP, nor (ii) based upon the Company's assessment of the likelihood of such contingent

or prospective liabilities eventually materialising. Based on the Company's estimates, the Company has determined that the Company Net

Assets (as defined under the Limited Recourse Loan Facility) are negative even taking into account the receipt of the proceeds of the Put

Option, and that currently no repayments of the LRLF are necessary. The Company will, however, continue to monitor the development of

its Company Net Asset position until the completion of the liquidation process, to consider whether any repayment of the LRLF needs to

be made.

However, this limitation on NN2's recourse against the Company shall not apply to the extent that the value of the Company Net Assets is

impaired, or NN2 suffers loss as a result of any breach by the Company of any provision of the Limited Recourse Loan Facility (or any

related finance document) other than the repeating representations / warranties thereunder or the provisions requiring payment of interest /

fees or repayment / prepayment of principal thereunder.

1.5.6.Information, consultation and litigation strategy undertakings

So long as any amount is outstanding under the Limited Recourse Loan Facility or the Lender's commitment thereunder is still in force, if

any Claim arises as a result of which the Company reasonably anticipates that it may make a utilisation under Facility B, the Company

must give notice to the Lender and Trafigura of the Claim. The Company shall:

-promptly notify NN2 and Trafigura of the Claim;

-subject to compliance with applicable law or confidentiality obligations to third parties, make available to NN2 and Trafigura all information

in its possession and control as reasonably requested by NN2 or Trafigura in connection with assessing, contesting, disputing, defending,

appealing or compromising the Claim, provided that NN2 and Trafigura shall maintain confidentiality and/or privilege with regard to such

information;

-keep NN2 and Trafigura informed of the progress / developments in respect of the Claim, and promptly provide any correspondence or

other information received in connection with the Claim;

-consult and take into account the views of NN2 and Trafigura as to the applicable legal advisors that will represent the Company, NN1, or

the applicable directors or officers. NNV shall also procure that such legal advisors provide fee estimates as requested by NN2 or

Trafigura;

-consult with and take into account the views of NN2 and Trafigura in relation to the conduct of the defense / negotiations / settlements in

respect of the Claim; and

-whilst any amount is outstanding under Facility B in relation to a civil Claim, not make any admission of Liability, agreement, settlement or

compromise in relation to that Claim without the prior written approval of Trafigura.

The Company must also consult with Trafigura prior to taking any action relating to insolvency or bankruptcy proceedings, including under

Book XX of the Belgian Code of Economic Law.

The Company is also obliged to provide NN2 with certain financial information, including quarterly cashflow forecasts (and any revisions

thereto required under the terms of the Limited Recourse Loan Facility), half-yearly financial statements and audited annual financial

statements, drawn up on a consolidated basis (to the extent the Company has subsidiaries) and in accordance with the accounting

principles agreed under the terms of the Limited Recourse Loan Facility.

1.5.7Relationship Agreement

At the completion of the Restructuring at 31 July 2019, the "Relationship Agreement" between Trafigura Group Pte Ltd and the Company

(dated 9 November 2015) was terminated. The Relationship Agreement governed the relationship between the Company (and the broader

Nyrstar group) and Trafigura Group Pte. Ltd. and its affiliated persons between its execution on 9 November 2015 and the completion of

the Restructuring on 31 July 2019.

1.5.8Other transactions with Trafigura

Other than as described in these disclosures, the Company has not entered into any commercial or other transactions with Trafigura in the

year ended 31 December 2024.

38/43

N°.

0888728945

F-cap 6.20

OTHER INFORMATION TO DISCLOSE

OTHER RIGHTS AND CONTINGENT LIABILITIES NOT REFLECTED IN THE BALANCE SHEET (including those which cannot be

quantified)

Parent company guarantees

Until 31 July 2019, the Company was the holding company of the Nyrstar group (consisting of the Company and its former subsidiaries). At

31 July 2019, when the Restructuring of the Nyrstar group was finalised, the Company was released of liabilities for existing financial

indebtedness and obligations owed under parent company guarantees of commercial or other obligations of the current members of the

Operating Group (all former subsidiaries of the Nyrstar group excluding NN1) (or indemnified by NN2 to the extent such guarantee

liabilities are not released). As at 31 December 2024, based on the information available to the Company, the Company has been fully

released from all contingent liabilities previously provided or irrevocably promised by the Company for debts and commitments of third

parties. The Company is fully indemnified in relation to any liability that may arise in this respect (see "Related party disclosures").

Contingent liabilities

In addition to the legal and regulatory claims and proceedings disclosed above, the Company is subject to risks related to tax matters as

the possible tax audits of certain fiscal years are not yet complete. Although the Company cannot estimate the risk related to these

possible tax audits as remote, it currently does not consider it probable that the outcome of these possible tax audits will have significant

impact on the financial position of the Company.

The Company has concluded that no additional provision is required at this time in relation to pending or potential tax reviews and that it is

currently unable to quantify the potential risks, but it continues to monitor and assess the situation.

39/43

N°.

0888728945

F-cap 10

Numbers of the joint industrial committees competent for the company:

SOCIAL BALANCE SHEET

224

STATEMENT OF THE PERSONS EMPLOYED

EMPLOYEES FOR WHOM THE COMPANY SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE

GENERAL PERSONNEL REGISTER

1001

1002

1003

During the period

Average number of employees

Full-time

Part-time

Total in full-time equivalents (FTE)

Codes Total 1. Men 2. Women

1011

1012

1013

Number of actual hours worked

Full-time

Part-time

Total

1021

1022

1023

Personnel costs

Full-time

Part-time

Total

Benefits in addition to wages

1033

1003

1013

1023

During the preceding period

Average number of employees in FTE

Number of actual hours worked

Personnel costs

P. Total 1P. Men 2P. Women

Codes

1033Benefits in addition to wages

40/43

N°.

0888728945

F-cap 10

Codes

1. Full-time 3. Total in full-time

equivalents

2. Part-time

At the closing date of the period

Number of employees

By nature of the employment contract

Contract for an indefinite period

Contract for a definite period

Contract for the execution of a specifically assigned work

Replacement contract

According to gender and study level

By professional category

105

110

111

112

120

113

121

133

130

134

132

primary education

secondary education

higher non-university education

university education

1200

1201

1202

1203

primary education

secondary education

higher non-university education

university education

1210

1211

1212

1213

Management staff

Salaried employees

Hourly employees

Other

Men

Women

HIRED TEMPORARY STAFF AND PERSONNEL PLACED AT THE DISPOSAL OF THE COMPANY

Codes

1. Hired temporary

staff

2. Hired temporary

staff and personnel

placed at the

company’s disposal

During the period

Average number of persons employed

Number of actual hours worked

Costs to the company

150

151

152

EMPLOYEES FOR WHOM THE COMPANY SUBMITTED A DIMONA DECLARATION OR WHO ARE RECORDED IN THE

GENERAL PERSONNEL REGISTER (continuation)

41/43

N°.

0888728945

F-cap 10

LIST OF PERSONNEL MOVEMENTS DURING THE PERIOD

ENTRIES

Codes

1. Full-time 3. Total in full-time

equivalents

2. Part-time

By nature of the employment contract

205

210

211

212

213

Contract for the execution of a specifically assigned work

Replacement contract

Contract for a definite period

Number of employees for whom the company submitted

a DIMONA declaration or who have been recorded in the

general personnel register during the period

Contract for an indefinite period

DEPARTURES

1. Full-time

Codes

2. Part-time 3. Total in full-time

equivalents

Number of employees whose contract-termination date

has been included in the DIMONA declaration or in the

general personnel register during the period

By nature of the employment contract

By reason of termination of contract

310

305

311

312

313

340

341

342

343

350

Retirement

Unemployment with extra allowance from enterprise

Dismissal

Other reason

Of which: the number of persons who continue to render

services to the company at least half-time on

a self-employment basis

Contract for an indefinite period

Contract for a definite period

Contract for the execution of a specifically assigned work

Replacement contract

42/43

N°.

0888728945

F-cap 10

INFORMATION ON TRAINING PROVIDED TO EMPLOYEES DURING THE PERIOD

Codes Men WomenCodes

5802

5801

5803

5811

5812

5813

58031

58032

58033

58131

58132

58133

5821

5822

5823

5841

5842

5843

5831

5832

5833

5851

5852

5853

Number of employees involved

Total of initiatives of formal professional training at the expense of the

employer

Number of actual training hours

Net costs for the company

of which gross costs directly linked to training

of which contributions paid and payments to collective funds

of which grants and other financial advantages received (to deduct)

Total of initiatives of less formal or informal professional training at the

expense of the employer

Total of initial initiatives of professional training at the expense of the

employer

Number of employees involved

Number of actual training hours

Net costs for the company

Number of employees involved

Number of actual training hours

Net costs for the company

43/43

Digitally signed by Gert Claes

(Signature)

DN: cn=Gert Claes (Signature)

Date: 2025.04.17 16:42:53

+02'00'

Gert Claes

(Signature)

Corporate Governance Statement

Nyrstar NV (“Nyrstar” or the “Company”) has prepared this Corporate Governance Statement in accordance with the Belgian Code on

Corporate Governance of 9 May 2019 (the “Belgian Code on Corporate Governance”) for this reporting year, ending on 31 December

2024.

This Corporate Governance Statement is included in the Company’s report of the Board of Directors on the statutory accounts for the

financial year ended on 31 December 2024 in accordance with article 3:6 §2 of the Belgian Code of Companies and Association.

Corporate Governance Charter

The Company adopted a Corporate Governance Charter in accordance with the Belgian Code on Corporate Governance, considering all

circumstances, including the current operations of the Company and the Company’s holding company status following the implementation

of the restructuring that was announced by the Company on 15 April 2019 and completed on 31 July 2019 (the “Restructuring”) and the

fact that the extraordinary shareholders meeting of the Company, on 9 December 2019, disapproved the continuation of the activities of

the Company (the “9 December 2019 Resolution”) and the various proceedings in which the Company is currently involved. The Company

applies the ten corporate governance principles contained in the Belgian Code on Corporate Governance. The Company also complies

with the corporate governance provisions set forth in the Belgian Code on Corporate Governance, except as explained below. The Board

of Directors intends to continuously review the provisions set forth in the Belgian Code on Corporate Governance in order to ensure that

any deviations continue to be justified in the Company’s circumstances.

In 2019, following the Restructuring, all members of the Management Committee, including the CEO, left, the Management Committee

was dissolved and the Company ceased to have any employees. In light of the current operations of the Company, related to its

functioning as a holding company and the various proceedings in which the Company is currently involved, and taking into account the 9

December 2019 Resolution, the Board of Directors believes that there are currently no management or executive functions to be

performed within Nyrstar by a CEO, Management Committee, executive management or employee and therefore deems it in the

Company’s best interest to continue operations and not to search and add a new CEO nor any other member of the Management

Committee or executive management or employee (see also below). To the extent the absence of a CEO, Management Committee,

executive management and/or any employee constitutes a deviation from any provision of the Belgian Code on Corporate Governance,

such as provisions 2.3, 2.5, 2.6, 2.9, 2.10, 2.11, 2.12, 2.14, 2.19 to 2.24, 3.14, 3.16, 3.20, 4.6, 4.12, 4.18, 4.21, 4.23, 5.1, 7.9 to 7.12 to

the extent these provisions refer to executive management or the CEO, this is explained by the elements set out in this paragraph. This

also explains the absence of a code of conduct which existed until 2019, which can be considered as a deviation from provision 2.18, all

while the Board performs its activities and the Company’s business objectives according to the strictest ethical standards and principles.

In addition, in deviation of provision 4.14 of the Belgian Code on Corporate Governance, the Company no longer has an independent

internal audit function. This deviation is explained by the current operations and circumstances of the Company, as described above. The

audit committee monitors the need for the creation of an independent internal audit function and, where appropriate, will call upon external

persons to conduct specific internal audit assignments and will inform the Board of Directors of their outcome.

Further, pursuant to provision 7.6 of the Belgian Code on Corporate Governance, a non-executive board member should receive part of

his or her remuneration in the form of shares in the Company. Considering the 9 December 2019 Resolution and the other circumstances

of the Company, the Company deviates from this provision.

The Corporate Governance Charter describes the main aspects of the corporate governance of the Company including its governance

structure, the terms of reference of the Board of Directors and its Committees and other important topics.

What constitutes good corporate governance will evolve with the changing circumstances of a company and with the standards of

corporate governance globally and must be tailored to meet those changing circumstances. The Board of Directors intends to update the

Corporate Governance Charter as often as required to reflect changes to the Company’s corporate governance. In light of the applicability

of the Belgian Code on Corporate Governance as of 1 January 2020, the current operations of the Company, the Company’s holding

company status and the 9 December 2019 Resolution, the Company has reviewed its Corporate Governance Charter during 2020. The

Corporate Governance Charter is available on the Company’s website at www.nyrstarnv.be. The Board of Directors approved the initial

charter on 5 October 2007. There were updated versions approved on several occasions. The current version was approved by the Board

of Directors on 3 December 2020. A copy of the Belgian Code on Corporate Governance can be found on

www.corporategovernancecommittee.be.

Code of Business Conduct

Nyrstar adopted a code of business conduct for all of Nyrstar’s personnel and sites which was applied until the completion of the

Restructuring. Post completion of the Restructuring and the exercise of the put option that the Company had in relation to its entire 2%

shareholding in NN2 NewCo Limited, which holds the former Nyrstar operational group, entitling it to sell such 2% to Nyrstar Holdings Plc

for a fixed amount of EUR 20 million (the “Put Option”). The Put Option was exercised on 28 July 2022 and since this date, the Company

has no such work force or sites and has no interest in the operating group of companies. As such, as at the date of this Corporate

Governance Statement and since the Company’s Corporate Governance Statement for the financial year ending on 31 December 2022,

the code of business conduct is no longer applied by the Company.

Board of Directors and Management Committee

Board of Directors

The table below gives an overview of the current members of the Company’s Board of Directors and their terms of office:

Name

Principal Function

within the Company

Nature of Directorship

Start of Term

End of Term

Martyn Konig

Chairman

Non-Executive

2015

2027

Carole Cable

Director

Non-Executive,

Independent

2013

2025

Anne Fahy

Director

Non-Executive,

Independent

2016

2028

Jane Moriarty

Director

Non-Executive,

Independent

2019

2027

Marc Taeymans

Director

Non-Executive,

Independent

2023

2027

Martyn Konig, Non-Executive Chairman, was appointed chairman in April 2016. Between 18 January 2019 and 31 July 2019, Mr Konig

did not qualify as independent director pursuant to article 526ter of the Belgian Companies Code because of his executive role within the

Company. He is also non-executive director of Euromax Resources Ltd (since May 2012). From June 2015 to July 2023, Mr Konig was

a consultant advisor to T Wealth Management SA, which has been separate from Galena Asset Management (a Trafigura affiliate) since

June 2015. Previously, from 2008, he was Executive Chairman and President of European Goldfields until its friendly takeover by

Eldorado Gold Corp for US$ 2.5 billion in 2012. He has also been a main board director of NM Rothschild and Sons Ltd. for 15 years and

held senior positions at Goldman Sachs and UBS. Mr. Konig is a barrister and also a Fellow of the Chartered Institute of Bankers.

Carole Cable, Non-Executive Director, is currently a Partner of the Brunswick Group, an international communications firm, where she

is the Joint Head of the energy and resources practice specialising in the metals and mining sector. Prior to her current position, she

worked at Credit Suisse and JPMorgan where she was a Mining Analyst and then moved into institutional equity sales covering the global

mining sector as well as Asia ex Japan. Before that, she worked for an Australian listed mining company. She is a Member of the Audit

Committee, and the Nomination and Remuneration Committee. Ms. Cable is a non-executive director of CQS Natural Resources Growth

and Income plc.

Anne Fahy, Non-Executive Director, formerly sat on the board of SThree Plc and was the chair of its Audit Committee. Furthermore, she

previously sat on the Board and chaired the Audit and Risk Committee of Coats Group Plc. She is also a Trustee of Save the Children

Global Ventures. Previously, she was chief financial officer of BP's Aviation Fuels business, having worked in a variety of finance and

finance-related roles in her 27 years at BP. She is the Chair of the Audit Committee and Member of the Nomination and Remuneration

Committee. She is a Fellow of the Institute of Chartered Accountants in Ireland and worked at KPMG in Ireland and Australia prior to

joining BP in 1988. She holds a Bachelor of Commerce from the University College Galway, Ireland.

Jane Moriarty, Non-Executive Director, currently sits on the Boards of NG Bailey Group Limited where she is Audit and Risk Chair,

Mitchells & Butlers plc where she is Senior Independent Director and Audit Chair; Tennants Consolidated Limited where she is Audit and

Risk Chair and Babcock International Group plc. She was previously a senior Restructuring partner with KPMG LLP in the UK where she

worked for 29 years. She is a Member of the Audit Committee and Chair of the Nomination and Remuneration Committee. She is a Fellow

of the Institute of Chartered Accountants in Ireland and holds a Bachelor of Business Studies from Trinity College Dublin.

Marc Taeymans, Non-Executive Director, has a career of almost 30 years with listed companies operating in an international context

(Fortis, BNP Paribas, Barco and Generale Bank). From 2013 to 2018, he was a director at the Institute of Company Lawyers. He has

also been an accredited mediator in civil and commercial matters and law professor at Thomas More University College between 2017

and 2025. He was appointed to the Company’s Board on 27 June 2023 and is a member of the Audit Committee and Nomination and

Remuneration Committee. Mr. Taeymans holds law degrees from KU Leuven and the University of Virginia.

The business address of each of the Directors is for the purpose of their directors’ mandate, Zinkstraat 1, 2490 Balen, Belgium.

Company Secretary

Anthony Simms, Head of Legal and External Affairs for the Company, was appointed Company Secretary to the Company effective

6 November 2019.

The Company Secretary advises the Board on all governance matters and reports to the Board on how procedures are complied with

and whether the Board acts in accordance with its statutory obligations and its obligations under the Articles of Association. The role of

the Company Secretary includes ensuring, under the discretion of the Chairman, good information flow within the Board and its

Committees and between management and directors, as well as facilitating induction and assisting with professional development as

required. He or she also assists the Chairman in the logistics associated with the affairs of the Board (information, agenda, etc.). Individual

directors have direct access to the Company Secretary.

The Board is responsible for appointing and dismissing the Company Secretary. It oversees that the person appointed as the Company

Secretary has the necessary skills and knowledge of corporate governance matters.

Management Committee

In 2019, following the Restructuring, all members of the Management Committee, including the CEO, left, the Management Committee

was dissolved and the Company ceased to have any employees. Since the completion of the Restructuring, the Company has utilised

the services of management consultants. Under the terms of the deed for the sale by the Company of assets and shares to NN2 Newco

Limited that was executed as part of the Restructuring (the “Sale Deed”), certain limited executive services were also provided to the

Company by NN2 Newco Limited until 28 July 2022 when the Put Option was exercised. These limited executive services were provided

to the Company at no charge and included certain finance, tax, corporate counsel, IT and administration services. Since the exercise of

the Put Option, these limited executive services have been provided to the Company through consultancy agreements.

General Information on Directors

No Director has:

(a) any convictions in relation to fraudulent offences or any offences involving dishonesty;

(b) except in the case of compulsory liquidations, at any time in the previous five years, been associated with any bankruptcy, receivership

or liquidation of any entity in which such person acted in the capacity of a member of an administrative, management or supervisory

body or senior manager:

(d) been a director with an executive function of any company at the time of, or within twelve months preceding, any receivership,

compulsory liquidation, creditors’ voluntary liquidation, administration, company voluntary arrangement or any composition or

arrangement with that company’s creditors generally or with any class of its creditors

except for the arrangement with the Company’s

creditors in the framework of the Nyrstar Group which was completed on 31 July 2019;

(e) been a partner in a partnership at a time of, or within twelve months preceding, any compulsory liquidation, administration or voluntary

arrangement of such partnership;

(f) been a partner in a partnership at the time of, or within twelve months preceding, a receivership of any assets of such partnership; or

(g) had any of his or her assets subject to receivership; or

(h) received any sanctions by any statutory or regulatory authorities (including designated professional bodies) or ever been disqualified

by a court from acting as a member of the administrative, management or supervisory bodies of a company or from acting in the

management or conduct of the affairs of any company.

Other Mandates

Other than set out in the table below, no Director has, at any time in the previous five years been a member of the administrative,

management or supervisory body or partner of any companies or partnerships. Over the five years preceding the date of this report the

Directors hold or have held in addition to their function within Nyrstar, the following main directorships or memberships of administrative,

management or supervisory bodies and/or partnerships:

Name

Current

Past

Martyn Konig

Euromax Resources

Newgold

Stemcor Group

NN2 Newco Limited

NN1 Newco Limited

Carole Cable

Brunswick Group

CQS Natural Resources Growth and Income

plc

Women in Mining UK

Anne Fahy

Save The Children Global Ventures

Interserve Plc

SThree Plc

Coats Group Plc

Save the Children International

Jane Moriarty

NG Bailey Group Limited

Mitchells & Butlers plc (listed on LSE)

Tennants Con

solidated Limited

Babcock International Group plc

(listed on

LSE)

Martin’s Financial No 1 Ltd

Martin’s Financial No 2 Ltd

Martin’s Properties Holdings Ltd

Martin’s Properties (Chelsea) Limited

NN2

Newco Limited

KPMG LLP

NN1 Newco

Limited

Martin’s Investments Limited

(and a number of

its subsidiaries)

Martin’s DevCo Limited

(and a number of its

subsidiaries)

Martin’s Financial Holdings Limited

The

Quarto Group Inc

Marc Taeymans

VJV-Organisatie vzw

Institute for Corporate Lawyers

Board of Directors

The Company has opted for a “one-tier” governance structure whereby the Board of Directors is the ultimate decision-making body, with

the overall responsibility for the management and control of the Company, and is authorised to carry out all actions that are considered

necessary or useful to achieve the Company’s purpose. The Board of Directors has all powers except for those reserved to the

shareholders’ meeting by law or the Company’s articles of association. At least once every five years, the Board of Directors is to review

whether the chosen governance structure is still appropriate, and if not, it should propose a new governance structure to the general

shareholders’ meeting. The Company reviewed its governance structure during 2020 to ensure that it continues to comply with the Belgian

Code on Corporate Governance, which applies compulsorily to reporting years beginning on or after 1 January 2020. Given the holding

company status since the Restructuring, the exercise of the Put Option and the 9 December 2019 Resolution, a one-tier structure is

assessed to be sufficient. In 2025, the Company will reassess whether the governance structure is still appropriate in accordance with

provision 1.1 of the Belgian Code on Corporate Governance.

Pursuant to Section 1.1 of the Company’s Corporate Governance Charter, the role of the Board of Directors is to pursue the success of

the Company by providing leadership and enabling risks to be assessed and managed.

The Board of Directors is assisted by a number of committees to analyse specific issues. The committees advise the Board of Directors

on these issues, but the decision-making remains with the Board of Directors as a whole, with the exception:

- as of 25 January 2023, of the Special Committee for the ongoing FSMA proceedings which has the exclusive power (i) to decide

at internal level and (ii) to represent the Company at external level, in respect of the FSMA sanction proceedings and

investigation (only, and limited to the time of these proceedings and investigation), and received a special proxy (“bijzondere

volmacht”) from the Board to that end; and

- as of 10 April 2024, of the Special Committee for the proceeding on the merits before the Antwerp Enterprise Court (Turnhout

division), which has the exclusive power (i) to decide at internal level and (ii) to represent the Company at external level, in

respect of the proceedings on the merits (including any appeals procedures) (only, and limited to the time of these proceedings

and interim measures requested and/or granted in the framework thereof), and received a special proxy (“bijzondere volmacht”)

from the Board to that end.

(see also “—Committees of the Board of Directors” below).

Pursuant to the Company’s articles of association and the Belgian Code of Companies and Associations, the Board of Directors must

consist of at least three directors. The Company’s Corporate Governance Charter provides that the composition of the Board of Directors

should ensure that decisions are made in the corporate interest. It should be determined on the basis of diversity, as well as

complementary skills, experience and knowledge. Pursuant to the Belgian Code on Corporate Governance, at least half of the directors

must be non-executive. Pursuant to the Belgian Code of Companies and Associations, at least one third of the members of the Board of

Directors must be of the opposite gender, where the minimum number required is rounded to the nearest whole number, and at least

three directors must be independent in accordance with, at least, the criteria set out in the Belgian Code on Corporate Governance. Such

provisions are complied with.

The directors are appointed for a term of no more than four years by the general shareholders’ meeting. They may be re-elected for a

new term. Proposals by the Board of Directors for the appointment or re-election of any director must be based on a recommendation by

the Nomination and Remuneration Committee. In the event the office of a director becomes vacant, the remaining directors can appoint

a successor temporarily filling the vacancy until the next general shareholders’ meeting. The shareholders’ meeting can dismiss the

directors at any time.

The Board of Directors elects a chair from among its non-executive members on the basis of his or her knowledge, skills, experience and

mediation strength. The chair is responsible for the leadership and the proper and efficient functioning of the Board of Directors.

The Board of Directors meets whenever the interests of the Company so require or at the request of one or more directors. In principle,

the Board of Directors will meet sufficiently regularly and at least six times per year. Given the exceptional circumstances the Company

has faced in 2024, related to the various letters sent by minority shareholders, preparations of the shareholders meetings, proceedings

and investigations in which the Company is currently involved, the Board has needed to meet more regularly. The decisions of the Board

of Directors are made by a simple majority of the votes cast. The chair of the Board of Directors has a casting vote. In 2024, the Chairman

at no time used his casting vote and all decisions of the Board were taken unanimously.

During 2024, 13 formal meetings of the Board of Directors were held. The Chair of the Board, assisted by the Company Secretary,

ensures that Board members are provided with accurate, concise, timely and clear information before the meetings and, where necessary,

between meetings so that they can make a knowledgeable and informed contribution to Board discussions.

Committees of the Board of Directors

The Board of Directors has set up an Audit Committee and a Nomination and Remuneration Committee, which are compliant with the

Belgian Code on Corporate Governance. Additionally, the Board of Directors has set up a Special Committee for the ongoing FSMA

proceedings on 25 January 2023, and a Special Committee for the proceedings on the merits before the Antwerp Enterprise Court

(Turnhout division) on 10 April 2024.

Audit Committee

The Audit Committee consists of at least three directors. All members of the Audit Committee are non-executive directors. All members

of the Audit Committee must be non-executive directors, and at least one member must be independent within the meaning of the Belgian

Code on Corporate Governance. The current members of the Audit Committee are Anne Fahy (Chairman), Jane Moriarty, Carole Cable

and Marc Taeymans. The current composition of the Audit Committee complies with the Belgian Code of Companies and Associations

and the Belgian Code on Corporate Governance.

The members of the Audit Committee have a collective competence in the business activities of the Company as well as accounting,

auditing and finance. The current Chair of the Audit Committee is competent in accounting and auditing as evidenced by her previous

role as Chief Financial Officer of BP’s Aviation Fuels business. According to the Board of Directors, the other members of the Audit

Committee also satisfy this requirement, as evidenced by the different senior management and director mandates that they have held in

the past and currently hold (see also “—Other mandates”).

The assignments of the Audit Committee can vary according to the circumstances. However, the Audit Committee mainly has the following

duties (article 7:99 §4 BCCA):

• informing the Board of the result of the audit of the annual accounts of the Company and explain how the audit

has contributed to the integrity of the financial reporting and what role the Audit Committee played in that

process;

• monitoring the overall financial reporting process and submit recommendations or proposals to ensure its

integrity;

• monitoring the effectiveness of the Company's overall internal control processes and risk management systems;

• monitoring the statutory audit of the annual accounts, including follow-up on questions and recommendations

made by the statutory auditor;

• reviewing and monitoring the independence of the statutory auditor, in particular, if applicable, regarding the

provision of additional non-audit services to the Company; and

• be responsible for the procedure for the selection of the statutory auditor in accordance with the law and make

a motivated recommendation to the Board as to the nomination or renewal of the mandate of the statutory

auditor.

In the area of financial and accounting information,

• the Audit Committee monitors the integrity of the financial information provided by Nyrstar, in particular by

reviewing the relevance and consistency of the accounting standards used by Nyrstar; it must inform the Board

of the outcome of the audit of the statutory accounts, and explain in what way the audit of aforementioned

accounts have contributed to the integrity of the overall financial reporting and what the role of the Audit

Committee was in this process;

• more particularly the Audit Committee verifies the quality and reliability of Nyrstar’s half-yearly and yearly

accounts submitted to the Board. It reviews management’s certification process on half-yearly and yearly

accounts. It ensures that the documents are a true reflection of business progress, that they have been drawn

up in accordance with legal requirements, and provide a response to the demands of the Financial Services

and Markets Authority (“FSMA”) or of any other authority to which Nyrstar is subject as a listed company;

• in the event of significant and unusual transactions where the accounting treatment may be open to different

approaches, the management informs the Audit Committee of the methods used and their justification;

• the Committee discusses significant financial reporting issues, if any, with both management and the statutory

auditor; and

• it reviews the additional report which the statutory auditor must submit to the Audit Committee in accordance

with article 11 of Regulation EU 537/2014 and the applicable Belgian legislation.

In the area of auditing and control,

• the Audit Committee is responsible for the selection procedure of the statutory auditor in accordance with the

applicable laws and regulations and makes recommendations to the Board relating to the appointment and

remuneration of the statutory auditor, to be further submitted by the Board to the Shareholders’ Meeting;

• it examines together with the statutory auditor the range and scope of the audit performed. The Audit Committee

examines the results of the external audit, as well as the reports issued by the statutory auditor to shareholders;

• it monitors the statutory auditor’s independence, and in particular that neither the Auditor(s) nor the companies

with which he or she (they) is (are) associated carry out any activity for Nyrstar other than external audit services

or other audit related and/or other permitted services, within the applicable limits; it examines on a regular basis,

a report from the statutory auditor describing all relationships between the statutory auditor and Nyrstar; and

• on a regular basis, the Audit Committee examines the additional fees charged by the statutory auditor to Nyrstar

in excess of the fees approved by the Shareholders’ Meeting as well as fees charged for non-audit or audit-

related services, within the applicable limits, to be disclosed in Nyrstar’s annual report; according to article 3:64

§ 4 BCCA, it approves, as the case may be, the duties and fees of the statutory auditor when these fees exceed

the annual fees approved by the Shareholders’ Meeting as well as the fees for permitted audit-related and non-

audit services in accordance with the relevant regulations and policies.

In the area of appreciation of risk and risk management,

• the Audit Committee monitors the overall risk management processes of the Company;

• the Audit Committee evaluates management's determination of areas where risk could significantly affect

Nyrstar’s financial situation and reputation;

• it revaluates on a regular basis that:

1. the procedures in place allow effectively high risks to be identified and their potential impact to be

estimated;

2. preventive or risk transfer measures limit the consequences in an acceptable fashion; and

3. specific arrangements are in place which the staff of the company may use, in confidence, to raise

concerns about possible improprieties in financial reporting or other matters;

• it reviews the statements included in the annual report on risk management.

When new legislation is envisaged which could have considerable effects on the accounts of Nyrstar, its financial situation or its income

in the short or long-term, the Audit Committee is informed of the implementation and impact of these, and also of implementation measures

approved by management. If required, it draws up recommendations in this regard to the Board.

As soon as possible after a meeting of the Audit Committee, the Chair of the Audit Committee presents the findings and recommendations

of the meeting to all members of the Board of Directors.

In principle, the Audit Committee meets as frequently as necessary for the efficiency of the operation of the Audit Committee, but at least

two times a year. At least once a year, the Audit Committee should meet the external auditors to discuss matters concerning the internal

rules and any matters arising from the audit process. As set out below, the Audit Committee has met the external auditors at least twice

in 2024. The members of the Audit Committee must have full access to the Chief Financial Officer to whom they may require access in

order to carry out their responsibilities. Following the completion of the Restructuring on 31 July 2019, in view of its circumstances,

including the current operations of the Company and the Company’s holding company status, the Company ceased to have an internal

audit function.

During 2024, three Audit Committee meetings were held.

Nomination and Remuneration Committee

The Nomination and Remuneration Committee consists of at least three directors. All members of the Nomination and Remuneration

Committee are non-executive directors. In line with the Belgian Code of Companies and Associations, the Nomination and Remuneration

Committee consists of a majority of independent, non-executive directors. The Nomination and Remuneration Committee is chaired by

the Chairman of the Board of Directors or another non-executive director appointed by the committee. The following directors are currently

members of the Nomination and Remuneration Committee: Jane Moriarty (Chair), Carole Cable, Anne Fahy and Marc Taeymans.

Pursuant to the Code of Companies and Associations, the Nomination and Remuneration Committee must have the necessary expertise

on remuneration policy, which is evidenced by the experience and previous roles of its current members.

The role of the Nomination and Remuneration Committee is to make recommendations to the Board of Directors with regard to the

appointment of directors and executive management and to make proposals to the Board on the remuneration policy for directors and

executive management.

Pursuant to the Restructuring, the 9 December 2019 Resolution and the fact that the Company no longer has an Executive Management

nor any employees, the Nomination and Remuneration Committee does not currently undertake any activities with regards to members

of executive management of the Company. Furthermore, the Nomination and Remuneration Committee does not currently undertake any

activities with regards to ensuring that appropriate talent development and leadership diversity programmes are in place within the

Company.

In principle, the Nomination and Remuneration Committee meets as frequently as necessary for the efficiency of the operation of the

committee, but at least once a year.

During 2024, two Nomination and Remuneration Committee meetings were held.

Special Committee for the FSMA proceedings

On 25 January 2023, the Board of Directors unanimously resolved to approve to adopt a governance structure for the management of

and representation as to the FSMA investigation and proceedings which would consist of a Special Committee comprising of one

independent director that was not in office on 30 October 2018 (i.e. Ms. Moriarty) and the Company’s two consultant managers (i.e. Mr.

Matej (CFO) and Mr. Simms (Head of External Affairs and Legal)) to facilitate the production of historical and factual information and

documents. Following the appointment of Mr. Taeymans to the Board on 27 June 2023, he was also appointed by the Board of Directors

as a member of the Special Committee for the FSMA proceedings.

The Board of Directors unanimously resolved to approve that the Special Committee would have the exclusive power (i) to decide at

internal level and (ii) to represent the Company at external level, in respect of the FSMA sanction proceedings and investigation (only,

and limited to the time of these proceedings and investigation), and would receive a special proxy (“bijzondere volmacht”) from the Board

to that end.

Further, the Board of Directors unanimously resolved to approve that the Special Committee would:

− (i) not report to the Board and (ii) would not solicit its prior approval nor submit draft documents for its review;

− have the right to ask questions to / request documents from the non-involved directors insofar (i) necessary for the Company’s

defence and (ii) related to fact-checking only;

− have the capacity to engage expert consultants and legal counsel deemed necessary by the Special Committee for the

management of the FSMA investigation and approve the payment of related costs and expenses; and

− act with unanimity and record minutes to be included in a minute register.

Special Committee for the proceedings on the merits

On 10 April 2024, the Board of Directors unanimously resolved to approve to adopt a governance structure for the management of and

representation of the Company as to the proceedings on the merits against (amongst others) the Company and some of its directors

following a summons before the Antwerp Enterprise Court (Turnhout division) by a group of shareholders of the Company dd. 29 May

2020, which would consist of a Special Committee comprising of one independent director that was not in office on 31 July 2019 (i.e. Mr.

Taeymans) and the Company’s two consultant managers (i.e. Mr. Matej (CFO) and Mr. Simms (Head of External Affairs and Legal)) to

facilitate the production of historical and factual information and documents.

The Board of Directors unanimously resolved to approve that the Special Committee would have the exclusive power (i) to decide at

internal level and (ii) to represent the Company at external level, in respect of the proceedings on the merits (including any appeals

procedures) (only, and limited to the time of these proceedings and interim measures requested and/or granted in the framework thereof),

and would receive a special proxy (“bijzondere volmacht”) from the Board to that end.

Further, the Board of Directors unanimously resolved to approve that the Special Committee would:

− (i) not report to the Board of Directors and (ii) would not solicit its prior approval nor submit draft documents for its review;

− have the right to ask questions / to request documents from the non-involved directors insofar (i) necessary for the Company’s

defence and (ii) related to fact-checking only;

− have the capacity to engage expert consultants and legal counsel deemed necessary by the Special Committee and approve

the payment of related costs and expenses;

− act with unanimity, it being understood that the approval of two (respectively one) committee member(s) suffices for any decision

to be validly taken by the Special Committee in the absence of the third (respectively second) committee member (for whatever

reason); and

− record minutes to be included in a minute register.

Activity Report and Attendance at Board and Committee Meetings during 2024

The table summarises the attendance of meetings of the Board of Directors and the respective committees of the Board of Directors by

their members in person or by conference call during 2023.

Name

Board Meeting

Attended

Audit

Nomination and

remuneration

Carole Cable

10 of 13

2 of 3

1 of 2

Martyn Konig

13 of 13

N/A

Anne Fahy

11 of 13

3 of 3

1 of 2

Jane Moriarty

12 of 13

3 of 3

2 of 2

Marc Taeymans

12 of 13

3 of 3

1 of 2

The topics discussed at the Board and Committee Meetings are in line with the role and responsibilities of the Board and its Committees

as set out in the Corporate Governance Charter, which in 2024, were mainly related to the various letters sent by minority shareholders,

preparations of the shareholders meetings, proceedings and investigations in which the Company is currently involved, the preparation

of the Company’s general shareholders’ meetings and financial information.

Independent Directors

A director will only qualify as an independent director if he or she meets at least the criteria set out in the Belgian Code on Corporate

Governance and to the extent that the Board of Directors has no indication of any element that could cast doubt on the director's

independence. When the Board of Directors submits the candidature of an independent director, it must confirm explicitly that it has no

indication of any element that would cast a doubt over the proposed director’s independence. In case any doubt could exist with respect

to the independence of a proposed director, the Board of Directors explains such indication(s) when it submits the candidature of an

independent director to the general meeting and sets out the reasons why it assumes that the candidate is indeed independent.

The Belgian Corporate Governance Code states that an independent director must fulfil the following conditions:

• Not be an executive, or exercising a function as a person entrusted with the daily management of the company or a related company

or person, and not have been in such a position for the previous three years before their appointment. Alternatively, no longer enjoying

stock options of the company related to this position;

• Not have served for a total term of more than twelve years as a non-executive board member;

• Not be an employee of the senior management (as defined in article 19,2° of the law of 20 September 1948 regarding the organisation

of the business industry) of the company or a related company or person, and not have been in such a position for the previous three

years before their appointment. Alternatively, no longer enjoying stock options of the company related to this position;

• Not be receiving, or having received during their mandate or for a period of three years prior to their appointment, any significant

remuneration or any other significant advantage of a patrimonial nature from the company or a related company or person, apart

from any fee they receive or have received as a non-executive board member;

• (a) Not hold shares, either directly or indirectly, either alone or in concert, representing globally one tenth or more of the company’s

capital or one tenth or more of the voting rights in the company at the moment of appointment; (b) Not having been nominated, in

any circumstances, by a shareholder fulfilling the conditions covered under (a);

• Not maintain, nor have maintained in the past year before their appointment, a significant business relationship with the company or

a related company or person, either directly or as partner, shareholder, board member, member of the senior management (as

defined in article 19,2° of the law of 20 September 1948 regarding the organisation of the business industry) of a company or person

who maintains such a relationship;

• Not be or have been within the last three years before their appointment, a partner or member of the audit team of the company or

person who is, or has been within the last three years before their appointment, the external auditor of the company or a related

company or person;

• Not be an executive of another company in which an executive of the company is a non-executive board member, and not have other

significant links with executive board members of the company through involvement in other companies or bodies;

• Not have, in the company or a related company or person, a spouse, legal partner or close family member to the second degree,

exercising a function as board member or executive or person entrusted with the daily management or employee of the senior

management (as defined in article 19,2° of the law of 20 September 1948 regarding the organisation of the business industry), or

falling in one of the other cases referred to above, and as far as the second bullet is concerned, up to three years after the date on

which the relevant relative has terminated their last term.

The resolution appointing the director mentions the reasons on the basis of which the capacity of independent director is granted.

The Company discloses in its annual report which directors are independent directors. An independent director who ceases to satisfy the

requirements of independence must immediately inform the Board of Directors.

Jane Moriarty, Carole Cable, Anne Fahy and Marc Taeymans are independent directors, and Martyn Konig has ceased to have that role

since he has taken on the executive Chairman role in the run-up to the Restructuring.

Performance Review of the Board, its Committees and its Members

The Board of Directors evaluates its own size, composition and performance and that of its committees on a continuous basis.

The evaluation assesses how the Board of Directors and its committees operate, checks that important issues are effectively prepared

and discussed, evaluate each director’s contribution and constructive involvement, and assesses the present composition of the Board

of Directors and its committees against the desired composition. This evaluation takes into account the members’ general role as director,

and specific roles as chair, chair or member of a board committee, as well as their relevant responsibilities and time commitment.

The evaluation exercise is usually performed by means of individual discussions between the Board members and the Company

Secretary. Appropriate action is taken on those items that require improvement.

The Nomination and Remuneration Committee further regularly reviews the composition, the size and the functioning of the Board of

Directors and the different committees within the Board of Directors. The latest assessment took into account different elements, among

others the composition and functioning of the Board of Directors and Committees, the thoroughness with which material subjects and

decisions are prepared and discussed, the actual contribution of each director in terms of presence at Board and/or Committee meetings

and the constructive involvement in the deliberation and resolutions, the evaluation whether the effective composition corresponds with

the desirable or ideal composition, the application of the corporate governance rules within the Company and its bodies, and an evaluation

of the specific roles such as Chairman of the Board and Chairman or member of a Board Committee. The Board of Directors acts on the

results of the performance evaluation.

Executive Management

See “Management Committee” above.

Conflicts of Interest

Directors are expected to arrange their personal and business affairs so as to avoid conflicts of interest with the Company. Any director

with a conflicting financial interest (as contemplated by Article 7:96 of the Belgian Code of Companies and Associations) on any matter

before the Board of Directors must bring it to the attention of its fellow directors, and his statements about the nature of the conflict of

interest is included in the minutes of the meeting of the Board of Directors. The director with a conflicting financial interest may not take

part in any deliberations or voting related to such decision or transaction. The Board of Directors also includes in the minutes a description

of the nature of the relevant decision or transaction and the financial consequences thereof for the Company. This part of the minutes is

included in full in the annual report of the Company. The minutes are also shared with the statutory auditor of the Company who describes

the financial consequences of such decisions in its report pursuant to Article 3:74 of the Belgian Code of Companies and Associations.

At the beginning of each Board meeting (or Board Committee meeting), directors declare whether they assess they have any conflict of

interest as set forth in article 7:96 of the BCCA regarding the items on the agenda.

Each director acts without conflict and always puts the interests of Nyrstar before his/her personal interests. Each director arranges

his/her personal and business affairs so as to avoid direct and indirect conflict of interest with Nyrstar. The directors have the duty to look

after the interests of all shareholders on an equivalent basis. Each director acts according to the principles of reasonableness and fairness.

All directors inform the Board of conflicts of interest as they arise and that could in their opinion affect their capacity of judgment.

Each director should, in particular, be attentive to conflicts of interests that may arise between Nyrstar, its directors, its significant or

controlling shareholder(s) and other shareholders. The directors who are proposed by significant or controlling shareholder(s) should

ensure that the interests and intentions of these shareholder(s) are sufficiently clear and communicated to the board in a timely manner.

The Board should act in such a manner that a conflict of interests, or the appearance of such a conflict, is avoided. In the possible case

of a conflict of interests, the Board should, under the lead of its chair, decide which procedure it will follow to protect the interests of

Nyrstar and all its shareholders. In the next annual report, the Board should explain why they chose this procedure. However, where there

is a substantial conflict of interests, the Board should carefully consider communicating as soon as possible on the procedure followed,

the most important considerations and the conclusions.

Where applicable, the rules and procedures of article 7:96 and 7:97 BCCA need to be complied with.

There are no outstanding loans granted by the Company to any of the persons mentioned in “—Board of Directors”, nor are there any

guarantees provided by the Company for the benefit of any of the persons mentioned in “—Board of Directors”.

None of the persons mentioned in “—Board of Directors” has a family relationship with any other of the persons mentioned in “—Board

of Directors”.

The company has reimbursed advisory costs of certain directors in relation to (statements made at) the annual shareholders meeting, in

particular statements addressed by certain shareholders to certain directors. Those costs were limited (in this case, below EUR

5,000). The reimbursement followed the general cost reimbursement policy by the Company, which is consistent with Provision 3.10 of

the Belgian Code on Corporate Governance, and the relevant director(s) did not assist decision-making in this respect consistent with

Provision 6.9 of the Belgian Code on Corporate Governance.

Dealing Code

With a view to preventing market abuse (insider dealing and market manipulation), the Board of Directors has established a dealing code.

The dealing code describes the declaration and conduct obligations of directors and certain other persons with respect to transactions in

shares or other financial instruments of the Company. The dealing code sets limits on carrying out transactions in shares of the Company

and allows dealing by the above-mentioned persons only during certain windows. A copy of the dealing code is available on the

Company's website (www.nyrstarnv.be).

Internal Control and Risk Management

General

The Nyrstar Board of Directors is responsible for the assessment of the effectiveness of Nyrstar’s internal controls. The Company takes

a proactive approach to risk management. The Board of Directors is responsible for ensuring that the nature and extent of risks are

identified on a timely basis with alignment to the Group’s strategic objectives and activities.

The Audit Committee plays a key role in monitoring the effectiveness of the Risk Management Framework and is an important medium

for bringing risks to the attention of the Board of Directors. If a critical risk or issue is identified by the Board or management, it may be

appropriate for all directors to be a part of the relevant risk management process.

The Company’s internal control and risk management systems require regular evaluation of the effectiveness of such internal controls to

ensure the Company’s risks are being adequately managed. The Company’s internal control and risk management systems are designed

to achieve the Company’s objectives.

Effective risk management enables the Company to achieve an appropriate balance between realising opportunities while minimising

adverse impacts.

This section gives an overview of the main features of the Company’s internal control and risk management systems which are currently

in place following completion of the Restructuring.

The Company’s internal control and risk management systems focus on the following key principles:

Understanding the External and Internal Environment

Understanding the internal and external business environment and the effect this has on Nyrstar's business strategy and plans. This

informs the Company’s overall tolerance to risk.

Consistent Methods for Risk Identification and Analysis of Risks, Existing Controls and Control Effectiveness

Implementing systems and processes for the consistent identification and analysis of risks, existing controls and control effectiveness.

Evaluating whether the level of risk being accepted is consistent with levels of risk acceptable to the Audit Committee.

Risk management and mitigation

Using innovative and creative thinking in responding to risks and taking action where it is determined that the Company is being exposed

to unacceptable levels of risk.

Stakeholder Engagement and Communication

Involving all Nyrstar stakeholders, such as shareholders, in managing risks and communicating identified key risks and controls.

Monitoring and Review

Regularly monitoring and reviewing our risk management framework, our risks and control effectiveness.

Critical Internal Controls

Nyrstar’s critical internal controls which were in place through to the completion of the Restructuring on 31 July 2019 are no longer

applicable, given the role of the Company as a holding company after the Restructuring and the lack of employees or operations, the

Board of Directors is responsible for all control and decision-making, with the exception, as of 25 January 2023, of the Special Committee

for the ongoing FSMA proceedings and, as of 10 April 2024, of the Special Committee for the proceedings on the merits before the

Antwerp Enterprise Court (Turnhout division). Both committees have the exclusive power (i) to decide at internal level and (ii) to represent

the Company at external level, in respect of respectively the FSMA sanction proceedings and investigation (only, and limited to the time

of these proceedings and investigation), and the proceedings on the merits before the Antwerp Enterprise Court (Turnhout division)

(including any appeals procedures) (only, and limited to the time of these proceedings and interim measures requested and/or granted

in the framework thereof), and received a special proxy (“bijzondere volmacht”) from the Board to that end (see also “—Committees of

the Board of Directors” above). The Board of Directors has tailored its controls to the current circumstances.

The Board however still applies corporate governance principles in all its decision-making. The Board performs its activities and business

objectives according to the strictest ethical standards and principles.

Nyrstar applies a comprehensive standard for financial reporting. The standard is in accordance with applicable Belgian GAAP accounting

standards and applicable Belgian legislation. The effectiveness and compliance with the standard for financial reporting is consistently

reviewed and monitored by the Audit Committee.

In order to ensure adequate financial planning and follow up, a financial budgeting procedure describing the planning, quantification, the

implementation and the review of the budget in alignment with forecasts, is closely followed.

Nyrstar continues to communicate the actual financial results to its shareholders bi-annually, but this is no longer supplemented on a

quarterly basis by interim management statements.

The Company is committed to the ongoing review and improvement of its policies, systems and processes.

Principal Shareholders

The Company has a relatively wide shareholder base located in various jurisdictions. The free float of the Company as at the date of this

report was 60.49%.

The table below provides an overview of the shareholders that notified the Company pursuant to applicable transparency disclosure rules,

up to the date of this report. Although the applicable transparency disclosure rules require that a disclosure be made by each person

passing or falling under one of the relevant thresholds, it is possible that the information below in relation to a shareholder is no longer

up-to-date.

Date of

Notification

% of the

voting rights

attached to

shares before

dilution

(1)

% of the

voting rights

attached to

shares on a fully

diluted basis

(1)

Urion Holdings (Malta) Ltd

(2)

.............................................................

18 Jan 2019

24.42%

Kris Vansanten, BEE INSPIRED BV, Quanteus Group BV, an unnamed

physical person, E3V & Partners BV, another unnamed physical person,

Etimar BV, four other unnamed physical persons, Galina maatschap,

three other unnamed physical persons, Toxon NV, Group Minerva NV,

another unnamed physical person, Querinjean BV, another unnamed

physical person, Spanassur BV, two other unnamed physical persons,

Martens-De Vuyst maatschap, another unnamed physical person, Zikojet

BV and forty-five further unnamed physical persons

28 Dec 2021

15.09%

Notes:

(1) The percentage of voting rights is calculated on the basis of the 109,873,001 outstanding shares.

(2) Urion Holdings (Malta) Ltd, a direct subsidiary of Trafigura Holdings Limited. According to the latest available information received by the

Company, as at the date of this report Urion held 26,830,622 shares representing 24.42% of the voting rights.

The above shareholders have no special voting rights nor control rights.

No other shareholders, alone or in concert with other shareholders, notified the Company of a participation or an agreement to act in

concert in relation to 3% or more of the current total existing voting rights attached to the voting securities of the Company.

Share Capital and Shares

On the date of this report, the share capital of the Company amounts to EUR 114,134,760.97 and is fully paid-up. It is represented by

109,873,001 ordinary shares, each representing a fractional value of (rounded) EUR 1.04 and representing one 109,873,001

of the

share capital. The Company’s shares do not have a nominal value.

Form and Transferability of the Shares

The shares of the Company can take the form of registered shares and dematerialized shares. All the Company’s shares are fully paid-

up and are freely transferable.

Currency

The Company’s shares do not have a nominal value, but reflect the same fraction of the Company’s share capital, which is denominated

in euro.

Voting Rights attached to the Shares

Each shareholder of the Company is entitled to one vote per share. Shareholders may vote by proxy, subject to the rules described in

the Company’s articles of association.

Voting rights can be mainly suspended in relation to shares:

• which are not fully paid up, notwithstanding the request thereto of the Board of Directors of the Company;

• to which more than one person is entitled, except in the event a single representative is appointed for the exercise of the voting

right;

• which entitle their holder to voting rights above the threshold of 5%, 7.5%, 10%, 15%, 20% and any further multiple of 5% of the

total number of voting rights attached to the outstanding financial instruments of the Company on the date of the relevant

shareholders’ meeting, in the event that the relevant shareholder has not notified the Company and the FSMA at least 20 days

prior to the date of the shareholders’ meeting in accordance with the applicable rules on disclosure of major shareholdings; and

• of which the voting right was suspended by a competent court or the FSMA.

Pursuant to the Belgian Code of Companies and Associations, the voting rights attached to shares owned by the Company are

suspended.

Dividends and Dividend Policy

All shares are entitled to an equal right to participate in the Company’s profits (if any). Pursuant to the Belgian Code of Companies and

Associations, the shareholders can in principle decide on the distribution of profits with a simple majority vote at the occasion of the

annual shareholders’ meeting, based on the most recent statutory audited financial statements, prepared in accordance with the generally

accepted accounting principles in Belgium and based on a (non-binding) proposal of the Company’s Board of Directors. The Company’s

articles of association also authorise the Board of Directors to declare interim dividends subject to the terms and conditions of the Belgian

Code of Companies and Associations.

The Company’s ability to distribute dividends is subject to availability of sufficient distributable profits as defined under Belgian law on the

basis of the Company’s statutory financial statements. In particular dividends can only be distributed if following the declaration and

issuance of the dividends the amount of the Company’s net assets on the date of the closing of the last financial year as follows from the

statutory (non-consolidated) financial statements (i.e., summarized, the amount of the assets as shown in the balance sheet, decreased

with provisions and liabilities, all as summarized in accordance with Belgian accounting rules), decreased with the non-amortized costs

of incorporation and extension and the non-amortized costs for research and development, does not fall below the amount of the paid-

up capital (or, if higher, the issued capital), increased with the amount of non-distributable reserves. In addition, prior to distributing

dividends, 5% of the net profits must be allotted to a legal reserve, until the legal reserve amounts to 10% of the Company’s share capital.

The Company’s legal reserve currently meets this requirement.

In view of the Restructuring, the Board of Directors have taken the decision not to propose to shareholders a distribution for the financial

year 2024. Any future dividends or other distributions will depend on the financial situation in which the Company finds itself at that time,

including elements such as repayment obligations under its loans.

Diversity policy

Consistent with the diversity requirements specified by the Belgian Code of Companies and Associations, at least one third of the

members of the Nyrstar Board of Directors is of the opposite gender.

Information that has an Impact in case of Public Takeover Bids

The Company provides the following information in accordance with Article 34 of the Royal Decree dated 14 November 2007:

i) The share capital of the Company amounts to EUR 114,134,760.97 and is fully paid-up. It is represented by 109,873,001 shares,

each representing a fractional value of (rounded) EUR 1.04 or one 109,873,001

of the share capital. The Company’s shares do not

have a nominal value.

ii) Other than the applicable Belgian legislation on the disclosure of significant shareholdings and the Company’s articles of association,

there are no restrictions on the transfer of shares.

iii) There are no holders of any shares with special control rights.

iv) The Company no longer has any share based plans.

v) Each shareholder of Nyrstar is entitled to one vote per share. Voting rights may be suspended as provided in the Company’s articles

of association and the applicable laws and articles.

vi) There are no agreements between shareholders which are known by the Company and may result in restrictions on the transfer of

securities and/or the exercise of voting rights.

vii) The rules governing appointment and replacement of board members and amendment to articles of association are set out in the

Company’s articles of association and the Company’s Corporate Governance Charter.

viii) The powers of the Board of Directors, more specifically with regard to the power to issue or redeem shares are set out in the

Company’s articles of association. The Board of Directors was not granted the authorization to purchase its own shares “to avoid

imminent and serious danger to the Company” (i.e., to defend against public takeover bids). The Company’s articles of association

do not provide for any other specific protective mechanisms against public takeover bids.

ix) At the date of the report, the Company is a party to the following significant agreements which, upon a change of control of the

Company or following a takeover bid can enter into force or, subject to certain conditions, as the case may be, can be amended, be

terminated by the other parties thereto or give the other parties thereto (or beneficial holders with respect to bonds) a right to an

accelerated repayment of outstanding debt obligations of the Company under such agreements.:

• the Limited Recourse Loan Facility with NN2 NewCo Limited entered into on 23 July 2019

No takeover bid has been instigated by third parties in respect of the Company’s equity during the previous financial year and the current

financial year.

Annual and General Meeting –24 June 2025

The Annual General Meeting of Shareholders will take place on 24 June 2025. At this meeting shareholders will be asked to consider

and, where applicable, approve amongst others the following matters:

•

Reports on the statutory financial statements

•

Approval of the statutory financial statements

•

Discharge from liability of the Directors

•

Discharge from liability of the Statutory Auditor

•

Approval of the Remuneration report

•

(Re-)approval of the Remuneration Policy

•

Re-appointment of Ms. Carole Cable

Remuneration Report

Introduction

The Company prepares a remuneration report relating to the remuneration of directors. This remuneration report is part of the Corporate

Governance Statement, which is a part of the annual report. The remuneration report will be submitted to the annual general shareholders’

meeting (“AGM”) for approval.

Remuneration policy

Nyrstar’s remuneration policy is designed to:

• enable Nyrstar to retain talented persons; and

• promote sustainable business performance.

The remuneration awarded to the members of the Board of Directors and the managers substantially changed following the

implementation of the restructuring that was announced by the Company on 15 April 2019 and completed on 31 July 2019 (the

“Restructuring”).

All members of the Executive Management were employees of Nyrstar Sales & Marketing AG, a legal entity which is part of the operating

group that was transferred to NN2 Newco Limited on the Restructuring. Immediately following the Restructuring, the Company no longer

had an Executive Management nor any employees.

Remuneration policy as of 2021

As the Company was not placed into effective liquidation during 2020, steps were taken to implement a remuneration policy in accordance

with article 7:89/1 of the Belgian Code of Companies and Associations. Such remuneration policy was submitted to and approved by the

general shareholders’ meeting on 29 June 2021 (the “Remuneration Policy”). Nyrstar has since not proposed any changes to be reflected

in the Remuneration Policy. As the Remuneration Policy was last approved four (4) years ago, the Remuneration Policy will be resubmitted

for approval to the general shareholders’ meeting taking place on 24 June 2025 in accordance with article 7:89/1, §3.

Remuneration and compensation in 2024

Directors

The level of pay for the Board of Directors is regularly assessed against both European peer companies as well as companies listed on

Euronext Brussels benchmark stock market index (BEL All-Share).

Remuneration

During 2024 the following gross remuneration was paid to the directors, pursuant to the decisions of the general shareholders’ meeting

held on 27 April 2011, as amended and supplemented from time to time. It is noted that the below remuneration is only fixed remuneration

and that the total amount of remuneration is therefore not split out between base salary and variable remuneration. In accordance with

the currently existing remuneration principles, non-executive directors do not receive variable remuneration nor are they entitled to other

benefits other than customary directors’ and officers’ insurance. No pension expenses were awarded.

Remuneration cost

Paid in cash

Martyn Konig

€ 200,000

Carole Cable

€ 70,000

€ 70,000, which consists of:

- a fixed fee of €50,000 per year for membership of the Board of

Directors;

- a fixed fee of €10,000 per year for membership of the Audit

Committee; and

- a fixed fee of €10,000 per year for membership of the Nomination

and Remuneration Committee.

Anne Fahy

€ 80,000

€ 80,000, which consists of:

- a fixed fee of €50,000 per year for membership of the Board of

Directors;

- a fixed fee of €20,000 per year for chairmanship of the Audit

Committee; and

- a fixed fee of €10,000 per year for membership of Nomination and

Remuneration Committee.

Jane Moriarty

€ 80,000

€ 80,000, which consists of:

- a fixed fee of €50,000 per year for membership of the Board of

Directors;

- a fixed fee of €10,000 per year for membership of the Audit

Committee;

- a fixed fee of €15,000 per year for chairmanship of the

Nomination and Remuneration Committee; and

- a one-off fee of €5,000 for membership of the FSMA Special

Committee (on the basis of the special authorisation to the Board

of Directors in the remuneration policy as approved on 29 June

2021 to set and revise, from time to time, the rules and level of

compensation for directors carrying out a special mandate).

Marc Taeymans

€ 85,000

€ 85,000, which consists of:

- a fixed fee of €50,000 per year for membership of the Board of

Directors;

- a fixed fee of €10,000 per year for membership of the Audit

Committee;

- a fixed fee of €10,000 per year for membership of the Nomination

and Remuneration Committee;

- a one-off fee of €5,000 for membership of the FSMA Special

Committee (on the basis of the special authorisation to the Board

of Directors in the remuneration policy as approved on 29 June

2021 to set and revise, from time to time, the rules and level of

compensation for directors carrying out a special mandate); and

- a one-off fee of €10,000 for chairmanship of the Merits Special

Committee (on the basis of the special authorisation to the Board

of Directors in the remuneration policy as approved on 29 June

2021 to set and revise, from time to time, the rules and level of

compensation for directors carrying out a special mandate).

Other benefits

The Company has implemented customary directors’ and officers’ insurance coverage (“D&O insurance”). The D&O insurance that was

placed for the benefit of the Company’s directors in 2024 has a liability limit of €1 million in aggregate. This insurance was brokered by

Aon and placed at a cost of approximately €207,028.

Certain Management Services

In 2019, all members left the Management Committee following the completion of the Restructuring and the Management Committee was

dissolved. Immediately following the Restructuring on 31 July 2019, the Company ceased to have any direct employees. Under the terms

of the deed for the sale by the Company of assets and shares to NN2 Newco Limited that was executed as part of the Restructuring (the

“Sale Deed”), certain limited executive services were provided to the Company by NN2 Newco Limited until the exercise of the put option.

The put option that the Company exercised on 28 July 2022, for a fixed amount of EUR 20 million, was in relation to its entire 2%

shareholding in NN2 NewCo Limited, which holds the former Nyrstar operational group (the “Put Option”). Up until the exercise of the

Put Option, these limited executive services were provided to the Company at no charge and included certain finance, tax, corporate

counsel, IT and administration services. Since the exercise of the Put Option, the Company has retained certain individuals to provide

financial, legal and administrative services through consultancy agreements.

Directors’ and other interests

Deferred Shares

In the year 2016 to 2018, the general shareholders' meeting approved that each of the non-executive directors referred to below (the

"Eligible Directors") would be remunerated for his or her Director's mandate for the period from the respective general shareholders’

meeting until the annual general shareholders' meeting of the following year in the form of "deferred shares units" of the Company, and

not in cash, subject to the conditions set out below. The remuneration in shares for each Eligible Director was limited to the portion set

out next to his or her name below (the "Eligible Share Remuneration") of the aggregate remuneration that applies to the director's mandate

of the relevant Eligible Director in accordance with the principles that have been determined by the annual general shareholders' meeting

of the Company held on 27 April 2011 and that otherwise would have been payable in cash (the "Eligible Remuneration"). The shares

will not vest immediately, but will effectively vest and be delivered on the earlier of (i) the end of the Director's mandate as an Eligible

Director, or (ii) a change of control over the Company. The shares are granted for free (i.e. for no additional consideration). Under the

terms of the deferred shares units, the number of shares to be granted to an Eligible Director shall be equal to (i) the amount of the

Eligible Remuneration that would otherwise have been paid in cash, divided by (ii) the average closing price of the Company's shares

during the ten trading days preceding the date of the respective general shareholders' meeting that approved each grant, whereby the

result is rounded down to the nearest whole number.

The current Eligible Directors and their respective Eligible Share Remuneration that have been paid in deferred shares are as follows:

(i) Ms. Anne Fahy: EUR 10,000 of her Eligible Remuneration; (ii) Ms. Carole Cable: 50% of her Eligible Remuneration; and (iii) Mr. Martyn

Konig: 100% of his Eligible Remuneration. The Company's Nomination and Remuneration Committee was authorised to further document

the grant and to determine the terms and conditions of the grant, which contain customary adjustment clauses to take into account and

mitigate the effect of corporate actions, dilutive transactions and similar events, such as (but not limited to) stock splits, reverse stock

splits, mergers and de-mergers, dividend payments, other distributions on shares, rights offerings, and share buy-backs.

The Board did not propose a remuneration in deferred share units of the Company for the non-executive directors at the annual general

shareholders’ meeting of the Company that was held on 25 June 2024.

The Company did not grant any Deferred Share Units to its Directors in 2024. In the period 2016 to 2019, Deferred Share Units were

granted to certain directors as approved by the respective AGMs in 2016 to 2018. The 2016, 2017 and 2018 AGM granted the following

Deferred Share Units to directors:

AGM 2016

AGM 2017

AGM 2018 for

year 2018

AGM 2018 for

year 2019

Total

Martyn Konig

27,285 DSU

37,282 DSU

34,494 DSU

34,361 DSU

133,422 DSU

Carole Cable

4,774 DSU

6,524 DSU

6,036 DSU

6,013DSU

23,347 DSU

Anne Fahy

1,364 DSU

1,864 DSU

1,725 DSU

1,718 DSU

6,671 DSU

Jane Moriarty

Total Shareholding

As at 31 December 2024, none of the directors in office held any Nyrstar shares.

Change in remuneration of other employees

The Company currently does not have any employees and has therefore not described the annual changes to the remuneration, the

annual changes to the development of the performance of the Company and the annual changes in the average remuneration of other

employees of the Company other than the directors of the Company, nor any ratios in this respect.